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ABSTRACT  
Nearly half of all HIV-positive individuals present with some form of HIV-
associated neurocognitive disorder (HAND). The experiments described in this 
thesis examined the structural changes that occur in the brain as a result of HIV 
infection. While previous work has established that HIV targets the basal ganglia 
and fronto-striatal systems and impacts cortical and white matter pathways, it 
was unknown whether these changes occur in the absence of HAND. The 
studies described here focused on cognitively asymptomatic HIV+ individuals 
(CAHIV+) without HAND as determined by widely accepted neuropsychological 
performance guidelines. 
Experiment 1 utilized diffusion tensor imaging (DTI) to examine HIV-
associated alterations in white matter (WM) fractional anisotropy (FA) in the 
absence of HAND in 23 HIV+ individuals and 17 control participants (HIV-) 
matched for age, education, and verbal IQ. The hypothesis was that CAHIV+ 
participants would show lower FA values than HIV- in the corpus callosum, 
	  vii 
frontotemporal, and parietal regions of interest (ROIs). CAHIV+ individuals 
demonstrated higher FA in the frontotemporal region and posterior corpus 
callosum, but lower FA in parietal WM relative to HIV- individuals. 
Experiment 2 utilized structural MRI to compare cortical thickness in 22 
CAHIV+ individuals and 19 control participants (HIV-) matched for age, 
education, and verbal IQ. The hypothesis was that CAHIV+ participants would 
have thinner frontal, temporal, and parietal regions than HIV- participants. 
Reduced cortical thickness measures were identified in the cingulate and 
superior temporal gyri, with increased cortical thickness measures in the inferior 
occipital gyrus, for HIV+ participants compared to HIV-.  
Experiment 3 examined the relationship between the structural alterations 
identified in Experiments 1 and 2, neuropsychological performance on tests 
sensitive to HAND identification, and immunological characteristics in 30 HIV+ 
participants and 28 HIV- control participants. As hypothesized, regional FA 
values, cortical thickness, and viral load were related to neuropsychological 
composite scores for CAHIV+, but not HIV-. 
Together, results from these three studies suggest that regional FA and 
cortical alterations identified in CAHIV+ patients may contribute to the cognitive 
deficits often seen in later stages of HIV disease. 
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CHAPTER ONE 
 
General Introduction 
 
OVERVIEW 
There are currently 32.1 million adults and children living with Human 
Immunodeficiency Virus (HIV) worldwide. These include an approximate 48,000 
individuals who are newly infected here in North America each year (UNAIDS, 
2013).  Since the advent of highly active antiretroviral therapies (HAART), the 
incidence of HIV-associated dementia (HAD) has dropped dramatically (Sacktor 
et al., 2002).  However, the prevalence of less severe HIV-associated 
neurocognitive impairment continues to rise as HIV+ individuals are living longer 
lives by taking advantage of new medicinal therapies (Cysique & Brew, 2009). 
Given the wide range of cognitive impairments seen in HIV-positive patients, the 
term HIV-associated neurocognitive disorders (HAND) was coined to 
encapsulate them all (McArthur, Steiner, Sacktor, & Nath, 2010).  
These impairments have been related to the neurodegenerative pathology 
of HIV, as triggered by the influx of HIV-infected monocytes and macrophages 
into the Central Nervous System (CNS), a condition known as HIV encephalitis 
(HIVE) (Budka, 1991; Gendelman, Lipton, Tardieu, Bukrinsky, & Nottet, 1994).  
While combined antiretroviral therapies (cARTs) have helped to reduce the 
incidence HAD, they are unable to altogether eliminate HIV infection in the CNS 
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(Masliah, DeTeresa, Mallory, & Hansen, 2000). This is not surprising given that 
the majority of antiretroviral medications do not penetrate the blood-brain barrier 
(Letendre et al., 2008). Additionally, while cART can control replication of the 
virus, latent forms of HIV that become integrated into the host’s genome have 
been detected in the CNS (Jordan, Bisgrove, & Verdin, 2003). It appears as 
though the brain actually serves as a reservoir for those latent strains of the 
virus. In the presence of the appropriate stimulus, latently infected cells will 
reactivate and begin producing infectious versions of the virus (Alexaki, Liu, & 
Wigdahl, 2008; Redel et al., 2009). As a result, the neurodegeneration caused by 
HIVE continues to progress slowly over the course of many years (Cook et al., 
2005; McArthur, 2004).  
It has been well established that HIV targets subcortical regions with 
particular affinity for the basal ganglia and fronto-striatal networks (J. R. Berger & 
Nath, 1997). This results in the presence of HIV-infected macrophages, 
microglia, and multinucleate giant cells in basal ganglia nuclei (Brew, 
Rosenblum, Cronin, & Price, 1995), caudate atrophy (Hestad et al., 1993; Stout 
et al., 1998), and basal ganglia hypermetabolism (Hinkin et al., 1995; van Gorp et 
al., 1992). More recently, neuroimaging studies have shown that the cortex and 
white matter pathways are impacted as well (Masters & Ances, 2014). However, 
it was unknown whether these changes occur in HIV+ patients without HAND.   
The purpose of this thesis was to examine the relationship between HIV-
related structural brain changes in the white matter and cortex, 
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neuropsychological performance on tests sensitive to HAND identification, and 
immunological characteristics in a group of cognitively asymptomatic HIV+ 
(CAHIV+) patients without HAND as compared to well-matched control 
participants (HIV-). In three distinct, but related investigations, neuroimaging 
techniques and neuropsychological testing were employed to understand this 
relationship. The studies described here focused on CAHIV+ without HAND as 
determined by widely accepted neuropsychological performance guidelines from 
the National Institute of Mental Health and National Institute of Neurological 
Diseases and Stroke (Antinori et al., 2007). Studying this relationship contributes 
to our understanding of the neurological compromise associated with HIV-
infection and highlights the brain regions most susceptible in the cognitively 
asymptomatic stages of the disease. Given that nearly 50% of all HIV-infected 
individuals suffer form some form of HAND (Griffin, Kang, Ma, & Zhang, 2015), 
such knowledge is clinically useful given the continuous development of and 
need for novel antiretroviral medications (Asahchop, Wainberg, Sloan, & 
Tremblay, 2012). 
The results of the first two experiments, detailed in chapters two and three 
of this dissertation, provide evidence for structural changes that take place in the 
brain as a result of HIV-infection in cognitively asymptomatic HIV+ patients. The 
third study, found in chapter four of this thesis, examines the relationship 
between these structural alterations, neuropsychological performance, and HIV-
specific immunological markers. Together, results from these three studies 
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suggest that regional white matter and cortical alterations identified in patients 
without HAND may contribute to the cognitive deficits seen in later stages of HIV 
disease. 
The focus of this introductory chapter is to provide the necessary 
theoretical background on which the remainder of this dissertation is based. First, 
the cellular and molecular mechanisms of HIV as it enters the brain will be 
detailed. The known neurological damage caused by HIV will then be highlighted 
in the white matter, cortex, and cognitive domains. The specific aims for each 
experiment, along with their predictions, follow. Finally, the general methods are 
outlined. 
Chapters two, three, and four encompass the background, methods, 
results, and discussion sections for each of the three distinct experiments. 
Chapter five gives a comprehensive conclusion to tie each of the previous 
studies together while emphasizing the significance of this work. 
 
MOLECULAR AND CELLULAR MECHANISMS OF HIV 
Shortly after initial infection, HIV enters the CNS where it primarily invades 
microglial cells and perivascular macrophages (Albright et al., 1999; He et al., 
1997; Wiley, Schrier, Nelson, Lampert, & Oldstone, 1986). The virus latches onto 
CD4 immunoglobulin receptors found on the surface of those cells while 
additional chemokine receptors such as CXCR4 and CCR5 allow for similar entry 
into lymphocytes and monocytes, respectively (Deng et al., 1996; Dittmar et al., 
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1997). Once a cell is infected, the HIV structural protein complex gp160 causes 
the cell membrane to fuse with the membrane of the virus, thus allowing the virus 
to enter the cell (E. A. Berger, Murphy, & Farber, 1999). Infected lymphocytes 
and monocytes cross the blood-brain barrier freely and release HIV throughout 
the CNS (Koenig et al., 1986). Additional proposed mechanisms for spreading 
the infection throughout the brain include cell-free virus penetration, (N. Q. Liu et 
al., 2002), release by infected microvascular endothelial cells (Albright, Soldan, & 
González-Scarano, 2003), and disruption of blood-brain barrier integrity via 
astrocytes (Eugenin, Clements, Zink, & Berman, 2011). 
Once infected, cells can cause synaptic injury and neuronal loss via a 
number of mechanisms. Some infected cells release neurotoxic chemokines and 
cytokines such as quinolinic acid, interleukin-1ß, and tumor necrosis factor 
(TNF)-α which increases blood-brain barrier permeability and allows easier 
passage for HIV into the CNS (Matsumoto et al., 1993; Mocchetti, Bachis, & 
Avdoshina, 2012). These neurotoxins have a diverse range, affecting white 
matter and numerous CNS structures (Kaul, Garden, & Lipton, 2001). The 
release of HIV viral proteins from infected cells can promote toxicity via both 
direct and indirect neurochemical cascades as well. These viral proteins include 
the HIV transcription factor Tat (Nath, 2002), envelope glycoprotein GP120 
(gp120), and Nef, a protein that aids in disease replication (van Marle et al., 
2004). While Nef has been mainly associated with oligodendrocyte dysfunction 
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(Radja, Kay, Albrecht, & Jolicoeur, 2003), much more is know regarding the roles 
Tat and gp120 play in neurodegeneration.  
When Tat is released from HIV-infected cells, it alters the blood brain 
barrier (Toborek et al., 2003) and interacts with other proteins to enter additional 
neurons (Y. Liu et al., 2000). Tat has an excitotoxic effect when it binds with N-
methyl-D-aspartate (NMDA) receptors so that excessive glutamate levels are 
released by cell, dysregulating neighboring NMDA receptors, and leading to 
neural injury (Haughey, Nath, Mattson, Slevin, & Geiger, 2001). Tat has been 
implicated in other neurotoxic events including nitric oxide synthesis (Nath, 1999) 
and depolarization of mitochondrial membranes (V. Li, Brustovetsky, & 
Brustovetsky, 2009). 
gp120 causes neurotoxicity in a variety of ways as well. Like Tat, gp120 
evokes apoptosis via the release of cytokines and glutamate (Kaul & Lipton, 
1999). However, it has also been shown to bind directly to chemokine receptors 
CXCR4 and CCR5 in neurons and astrocytes, respectively, resulting in apoptosis 
(Hesselgesser et al., 1998; Zheng et al., 1999). While increasing the production 
of destructive cytokines and glutamate, gp120 has additionally been implicated in 
the reduction of brain derived neurotrophic factor (BDNF), which is vital for 
neuronal survival (Nosheny, Bachis, Acquas, & Mocchetti, 2004). 
Tat and gp120 have shown selective toxicity to striatal neurons (Brew et 
al., 1995; Kure, Lyman, Weidenheim, & Dickson, 1990). Additionally, the basal 
ganglia and hippocampus are rich in NMDA receptors (Monaghan & Cotman, 
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1985) and dependent upon BDNF for normal functioning (Xie, Hayden, & Xu, 
2010; Xu et al., 2000), both of which are targets of HIV proteins. Given the 
chemical mechanisms of these viral proteins, it is unsurprising that while some 
general damage to the CNS occurs with HIV infection, the disease does have 
reliable regional specificity. 
 
HIV PATHOLOGY 
Imaging white matter in HIV 
 In patients with HIVE, it has been determined that HIV-infected 
macrophages and multinucleated giant cells target cerebral white matter (WM) 
with regional specificity for the corpus callosum and internal capsule (Gosztonyi, 
Artigas, Lamperth, & Webster, 1994).  This leads to diffuse WM pallor that 
becomes more prominent as the disease advances (Price et al., 1988). A number 
of radiological studies have demonstrated overall WM volume loss in HIV 
(Aylward et al., 1993; J. R. Berger & Nath, 1997; Du et al., 2012; Jernigan et al., 
1993; Ragin, Storey, Cohen, Epstein, & Edelman, 2004; Stout et al., 1998). 
Using more nuanced magnetic resonance imaging techniques, HIV-associated 
changes have been particularly well-documented in the corpus callosum (Chang 
et al., 2008; Filippi, Ulug, Ryan, Ferrando, & van Gorp, 2001; Hoare et al., 2011, 
2012; Leite et al., 2013; Müller-Oehring, Schulte, Rosenbloom, Pfefferbaum, & 
Sullivan, 2010; Nir et al., 2014; Pfefferbaum et al., 2009; Pfefferbaum, 
Rosenbloom, Adalsteinsson, & Sullivan, 2007; Schulte, Müller-Oehring, Javitz, 
	  8 
Pfefferbaum, & Sullivan, 2008; Tate et al., 2011; Thurnher et al., 2005; Wright, 
Heaps, Shimony, Thomas, & Ances, 2012; Wu et al., 2006) and to a lesser 
extent in the corona radiate or internal capsule/centrum semiovale (Hoare et al., 
2012; Leite et al., 2013; Nir et al., 2014; Pomara, Crandall, Choi, Johnson, & Lim, 
2001; Wright et al., 2012). 
For HIV positive participants, altered white matter, as measured by 
fractional anisotropy (FA) values obtained via Diffusion Tensor Imaging (DTI), 
has been reported across callosal regions (Hoare et al., 2011, 2012; Leite et al., 
2013; X. J. Li et al., 2015; Müller-Oehring et al., 2010; Nir et al., 2014) and 
specifically in the genu (Corrêa et al., 2015; Filippi et al., 2001; Schulte et al., 
2008; V. M. Tang et al., 2015; Thurnher et al., 2005) and splenium (Filippi et al., 
2001; Wu et al., 2006).  Recently, reduced FA in the corpus callosum 
demonstrates a significant relationship with duration of infection (Wright et al., 
2015), and has been found as early as one hundred days of infection (Ragin et 
al., 2015).  
 
Imaging the cortex in HIV 
Early imaging studies utilized qualitative, clinical definitions of atrophy via 
visual examination of MRI films by neuroradiologists to examine sulcal width in 
different stages of HIV infection across the cortex. However, there was little 
uniformity among the results. Some studies reported a greater proportion of 
participants with an Acquired Immunodeficiency Syndrome (AIDS) diagnosis as 
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having enlarged sulci when compared to HIV- or pre-AIDS HIV+ participants 
(Harrison et al., 1998; Poutiainen et al., 1993). Additional work evaluating a large 
group of HIV+ participants with mild cognitive impairment failed to find any 
cortical atrophy (Dooneief et al., 1992). It was also reported that the most 
pronounced cortical atrophy in both neurosymptomatic and symptom-free HIV+ 
patients was localized within the temporal lobes, though the majority of patients 
did not have atrophy at all (Elovaara et al., 1990).  
Overall cortical atrophy associated with HIVE has been documented using 
quantitative neuroimaging methods (Chrysikopoulos, Press, Grafe, Hesselink, & 
Wiley, 1990; Post et al., 1988; Wiley et al., 1991) and pathological assessment 
(Miller et al., 1997) as well. One postmortem study demonstrated that deceased 
HIV+ participants possessed increased levels of cerebral spinal fluid and a 
decreased cortical volume (Archibald et al., 2004). Additionally, medically 
symptomatic HIV+ men demonstrated a more rapid loss of cortical tissue than 
asymptomatic HIV+ or seronegative individuals (Stout et al., 1998). Studies 
examining regional volume loss have reported significant reduction of posterior 
gray matter in HIV+ participants suffering from dementia as compared to HIV+ 
patients without HAD and HIV- individuals (Aylward et al., 1995) and local cortical 
thinning in primary sensory, motor, and premotor cortex in AIDS patients with 
cognitive impairment was found to be related to low CD4 count (Thompson et al., 
2005).  
More recent studies have assessed cortical thickness in HIV+ patients and 
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identified atrophy in the anterior cingulate and temporal cortices (Küper et al., 
2011), posterior and inferior temporal lobes, parietal lobes, and in the cerebellum 
(Becker et al., 2012). However, another group found no significant differences in 
cortical thickness between HIV+ patients and control participants (Corrêa et al., 
2016).  Finally, a reduction in cortical thickness in the bilateral insula, orbitofrontal 
and temporal cortices and right superior frontal cortex in patients using HAART, 
with detectable HIV-deoxyribonucleic acid (DNA) in peripheral blood, compared 
with HIV patients using HAART without HIV-DNA detected in peripheral blood 
has been documented as well (Kallianpur et al., 2012).  
 
COGNITIVE IMPAIRMENT IN HIV 
There is an extensive body of literature suggesting that fronto-striatal 
dysfunction is associated with HIV (Chang et al., 2001; Ernst, Chang, & Arnold, 
2003; Hinkin et al., 2002; Llorente et al., 1998; Martin et al., 2001; Sahakian et 
al., 1995; Stout et al., 1995; Villa et al., 1996). A number of studies have reported 
cognitive deficits in the asymptomatic adult HIV+ population defined as infection 
with HIV prior to receiving either a diagnosis of AIDS, medically symptomatic HIV 
status, or cognitively symptomatic HIV status.  The characteristic 
neuropsychological symptomatology includes working memory dysfunction 
(Chang et al., 2001; Ernst, Chang, Jovicich, Ames, & Arnold, 2002; Hinkin et al., 
2002; Martin et al., 2001; Stout et al., 1995), higher order attentional 
disturbances with a lack mental flexibility (Sahakian et al., 1995), general motor 
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and psychomotor speed decreases (Llorente et al., 1998; Villa et al., 1996), and 
cognitive slowing culminating as a decrease in reaction time (Karlsen, Reinvang, 
& Frøland, 1992; Law et al., 1995; Mellgren et al., 2000) especially in tasks 
requiring response inhibition (Hinkin, Castellon, Hardy, Granholm, & Siegle, 
1999; Llorente et al., 1998).  More recently, visuospatial difficulties have been 
identified as well (Bogdanova, Neargarder, & Cronin-Golomb, 2008; Olesen, 
Schendan, Amick, & Cronin-Golomb, 2007).  
In an effort to standardize the criteria used in the classification of HAND 
for HIV+ patients, testing the following set of neuropsychological domains has 
been recommended by the National Institute of Mental Health and National 
Institute of Neurological Diseases and Stroke: Verbal/language, attention/working 
memory, abstraction/executive function, memory (learning and recall), speed of 
information processing, and motor skills (Antinori et al., 2007). The same group 
proposed a z-score based algorithm to assist in standardized diagnostic 
classification of HAND and clarified three different levels of impairment: 
asymptomatic neurocognitive impairment (ANI), mild neurocognitive disorder 
(MND), and HIV-1-associated dementia (HAD). 
  
SPECIFIC AIMS OF THIS THESIS 
The occurrence and onset of damage to cortical regions and white matter 
pathways in cognitively asymptomatic HIV+ individuals has yet to be fully 
defined.  The main objective of this thesis is to examine HIV-related structural 
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brain changes in a group of cognitively asymptomatic HIV patients as compared 
to well-matched control participants using structural magnetic resonance imaging 
(MRI) techniques. This was achieved by utilizing neuroimaging and 
neuropsychological methods in three independent but interrelated experiments.  
In Experiment #1, DTI was employed to examine white matter alterations 
in cognitively asymptomatic individuals with HIV. In Experiment #2, cortical 
thickness measurements calculated from Magnetic Resonance Imaging scans 
were used to examine structural changes in the cerebral cortex in cognitively 
asymptomatic individuals with HIV. In Experiment #3, neuropsychological 
measures were used to characterize the cognitive profile of each participant in 
order to examine the relationship between the imaging measures collected in 
Experiments #1 and #2, cognitive performance on a series of neuropsychological 
tests, and immunological characteristics.  
 
Experiment 1: Examination of white matter alterations in cognitively 
asymptomatic individuals with HIV using Diffusion Tensor Imaging 
(Chapter 2) 
RATIONALE. Diffuse WM pallor is one of the most prominent features of 
advanced HIV disease (Price et al., 1988) and its severity has been associated 
with HAD (Gray et al., 1996).  However, few studies have used DTI to examine 
WM in cognitively asymptomatic patients living with HIV.  Previous DTI studies 
concluded that the method is sensitive enough to detect subtle WM changes 
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associated with HIV.  Whole brain differences (Ragin et al., 2004) and regional 
alterations in the corpus callosum (Chang et al., 2008; Filippi et al., 2001; Hoare 
et al., 2011, 2012; Leite et al., 2013; Müller-Oehring et al., 2010; Nir et al., 2014; 
Pfefferbaum et al., 2009, 2007; Schulte et al., 2008; Tate et al., 2011; Thurnher 
et al., 2005; Wright et al., 2012; Wu et al., 2006), frontal WM (Pomara et al., 
2001; Thurnher et al., 2005; Wu et al., 2006), internal capsule (Pomara et al., 
2001), and hippocampus (Thurnher et al., 2005) were noted in the HIV groups as 
well. Many of these previous investigations did not carry out a full 
neuropsychological assessment using the updated criteria for HAND to exclude 
HIV+ participants with ANI, MND, or HAD (Filippi et al., 2001; Hoare et al., 2012; 
Leite et al., 2013; Müller-Oehring et al., 2010; Pfefferbaum et al., 2009, 2007; 
Ragin et al., 2004; Schulte et al., 2008; Tate et al., 2010; Thurnher et al., 2005; 
Wright et al., 2012). Other studies actively recruited subjects with major cognitive 
deficits or dementia as part of their study (Pomara et al., 2001; Ragin et al., 
2004; Wu et al., 2006) or focused on a specific subset of the HIV+ population 
including the elderly (Nir et al., 2014), children with vertical transmission (Hoare 
et al., 2015), patients with HIV subtype C (Hoare et al., 2011), or newly infected 
patients (Ragin et al., 2015). In the studies that specifically included cognitively 
asymptomatic HIV+ individuals, one only reported the relationship with a global 
cognitive deficit score as opposed to individual domains (Chang et al., 2008). 
Another group used tract-based special statistics (TBSS) to calculate DTI 
measures across whole brain white matter skeletons for HIV-infected participants 
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with and without cognitive impairment as compared to healthy control participants 
(Zhu et al., 2013). 
This study screened for deficits indicative of dementia using the HIV 
Dementia Screening Scale (Power et al., 1995) in conjunction with a series of 
neuropsychological tests containing measures sensitive in detecting early HIV-
related cognitive impairments (Heaton, et al. 1995). Following the updated 
nosology from The National Institute of Mental Health and The National Institute 
of Neurological Diseases and Stroke (Antinori et al., 2007), HIV+ patients were 
categorized as cognitively asymptomatic (HIV+CA), having asymptomatic 
neurocognitive impairment (ANI), having mild neurocognitive impairment (MND), 
or having HIV-associated dementia (HAD). Only the DTI measures from HIV+CA 
individuals were used in the comparative analysis with match HIV- control 
participants. Experiment 1 includes a thorough regional analysis while focusing 
on WM regions previously associated with HIV-infection including the left, right, 
and central posterior corpus callosum, central anterior callosum, left and right 
internal capsule, left and right parietal WM, left and right parietoccipital WM, 
frontotemporal WM, and left and right temporal WM. 
HYPOTHESIS. As it is well documented that WM pallor is a prominent 
feature of advanced HIV (Price et al., 1988) with evidence that its severity is 
associated with HAD (Gray et al., 1996), it was hypothesized that regional WM 
tissue alterations occur in patients without HAND. Based on previous imaging 
studies in HIV, white matter changes were predicted to occur regionally in the 
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corpus callosum (Chang et al., 2008; Filippi et al., 2001; Hoare et al., 2011, 2012; 
Leite et al., 2013; Müller-Oehring et al., 2010; Nir et al., 2014; Pfefferbaum et al., 
2009, 2007; Schulte et al., 2008; Tate et al., 2011; Thurnher et al., 2005; Wright 
et al., 2012; Wu et al., 2006), frontotemporal WM (Pomara et al., 2001; 
Thompson et al., 2005; Thurnher et al., 2005; Wu et al., 2006), internal capsule 
(Pomara et al., 2001), and parietal WM (Becker et al., 2012; Thompson et al., 
2005) of CAHIV+ participants as compared to matched HIV- control participants. 
This study used voxel-based t-tests to show that these changes occur in patients 
without HAND. 
EXPERIMENT #1. Whole-head, high-resolution DTI scans (Siemens, 
Erlangen Germany, 1.5 T Sonata System; TR=14.4s, TE=81ms, slice thickness = 
2mm isotropic, 60 slices total, acquisition matrix 128mm x 128mm (FOV=256mm 
x 256mm), 5/8 partial Fourier, 6 averages, 6 non-collinear directions with b-value 
= 700s/mm2, and 1 image, the T2 weighted ‘lowb’ image, with b-value = 0s/mm2) 
were obtained for each participant. Custom tools were used in conjunction with 
software available as part of the Freesurfer (Martinos Center for Biomedical 
Imaging, Charlestown, Mass) and FSL (FMRIB, Oxford, UK) processing streams. 
Fractional anisotropy (FA) maps were acquired from the calculated diffusion 
tensor (Pierpaoli & Basser 1996).  
 
Experiment 2: Examination of structural changes in the cerebral cortex in 
cognitively asymptomatic individuals with HIV using cortical thickness 
	  16 
measurements calculated from Magnetic Resonance Imaging scans 
(Chapter 3) 
RATIONALE. The occurrence and onset of HIV-associated damage to 
cortical regions and the specific regional patterns of cortical alteration has not yet 
been fully defined for patients free from HAND. While other authors have 
previously evaluated cortical thickness of HIV-positive patients and have found 
diffuse brain atrophy, few studies have use sMRI to calculate cortical thickness in 
cognitively asymptomatic patients living with HIV. The majority of these previous 
investigations did not carry out a full neuropsychological assessment using the 
updated criteria for HAND to exclude HIV+ participants with ANI, MND, or HAD  
(Becker et al., 2012; Küper et al., 2011; Thompson et al., 2005). Other authors 
included dementia patients as part of their study (Aylward et al., 1993; Patel et 
al., 2002), only recruited subjects over 40 (Kallianpur et al., 2012) or 50 (Becker 
et al., 2012) years old, or focused on patients with executive function deficits 
(Corrêa et al., 2016). 
As in Experiment 1, this study screened for deficits indicative of dementia 
by using the HIV Dementia Screening Scale (Power, Selnes, Grim, & McArthur, 
1995) in conjunction with a series of neuropsychological tests containing 
measures sensitive in detecting early HIV-related cognitive impairments (Heaton 
et al., 1995) that followed the recommendations from The National Institute of 
Mental Health and The National Institute of Neurological Diseases and Stroke for 
HAND classification (Antinori et al., 2007). In experiment 2 cortical thickness 
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measures were compared between CAHIV+ and HIV- participants to determine 
whether cortical atrophy is present when HAND is not. Using automated surface 
reconstruction procedures to measure the thickness of the cerebral cortex from 
high-resolution magnetic resonance (MR) images (Fischl and Dale, 2000) 
allowed for the identification of regional cortical changes in CAHIV+ individuals 
by providing regionally specified measurements of atrophy across the cortical 
mantle in regions previously associated with HIV-induced damage. 
HYPOTHESIS. Based on the findings from previous investigations of 
cortical thickness studies in the HIV+ population, it was hypothesized that 
patterns of reduced cortical thickness will be apparent in CAHIV+ participants in 
comparison with HIV- control participants. Specifically, this reduced thickness 
was predicted to be regionally apparent in posterior areas (Aylward et al., 1995), 
cortex surrounding the central sulcus (Kallianpur et al., 2012; Thompson et al., 
2005), the temporal (Becker et al., 2012; Elovaara et al., 1990; Kallianpur et al., 
2012; Küper et al., 2011) and parietal lobes (Becker et al., 2012).  This pattern of 
cortical degeneration was predicted to be evident in patients free from HAND.  
EXPERIMENT #2. High-resolution T1-weighted MPRAGE scans were 
obtained on a 1.5 Tesla Siemens Sonata scanner (Imaging parameters: 
resolution 1.3 x 1.3 x 1 mm, echo time (TE) = 3.2 or 3.0 ms, repetition time (TR) = 
2730 ms, inversion time (TI) = 1000 ms, flip angle = 7o, field of view (FOV) = 
256x256 mm, matrix = 192x256). Two scans were collected, motion corrected, 
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and averaged to create a single high-signal, high-contrast volume for each 
participant.  
The averaged volume was then used to create representations of the gray 
matter/white matter boundary for each participant (Dale, Fischl, & Sereno, 1999; 
Dale & Sereno, 1993). Cortical thickness measurements were then calculated by 
measuring the distance between gray matter/white matter and gray 
matter/cerebrospinal fluid surfaces at each surface vertex across the cortical 
mantle before being mapped onto the inflated surface of each participant (Dale & 
Sereno, 1993; Fischl, Sereno, & Dale, 1999).  
 
Experiment 3: Regional white and gray matter alterations are related to 
performance measures of HIV-associated neurocognitive disorder (Chapter 
4) 
RATIONALE. Cognitive change in HIV has previously been associated 
with cortical atrophy, white matter alterations, and immunological markers of HIV 
infection. Cortical atrophy in HIV+ participants has been associated with slowed 
information processing (Harrison et al., 1998) and poor memory test performance 
(Harrison et al., 1998; Poutiainen et al., 1993).  Whole brain DTI measurements 
(Ragin et al., 2004) and regional DTI measures (Wu et al., 2006; Zhu et al., 
2013) correlate with cognitive deficits in HIV patients as well. Low current and 
nadir CD4 counts have been associated with cortical alterations in HIV+ patients 
(Jernigan et al., 2011; Thompson et al., 2005), while higher CD4 counts have 
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been related to higher FA values in the parietal lobe (Gongvatana et al., 2011). 
Relationships between cortical thickness, WM FA, and immunological 
characteristics had not yet been examined together in CAHIV+ patients. 
Therefore, the overall goal of this study was to yield valuable information 
regarding the extent to which structural imaging variables predict cognitive 
performance in patients free from HAND. 
 
HYPOTHESIS. It was hypothesized that regional FA values, cortical thickness, 
and viral load would be related to neuropsychological composite scores for 
CAHIV+ individuals, but not HIV- control participants. The HIV-associated 
alterations in cortical ROIs and DTI FA values are predicted to correlate 
significantly with one another in CAHIV+ participants as well. Even with no 
evidence of cognitive decline in HIV+CA participants, regression analyses are 
predicted to reveal relations between structural measurements and 
neuropsychological performance in CAHIV+ participants when compared with the 
HIV- control participants.   
 
EXPERIMENT #3. For all participants, volumes of the cortical ROIs and 
DTI ROI FA values were correlated with neuropsychological test performance 
within SPSS Statistics, version 23.0. In the HIV+ patients, current CD4 count, 
duration of illness, and viral load were correlated with the other variables as well. 
Finally, to identify whether cortical thickness, WM integrity, and immunological 
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markers of HIV-infection affect neuropsychological performance, stepwise 
multivariate linear regressions were carried out within SPSS as follows: 
CD4 + viral load + duration of illness + Cortical ROI thickness + DTI ROI 
FA values à Neuropsychological Performance	  
Cortical ROIs and DTI ROI FA values were calculated Experiments 2 and 1, 
respectively. Neuropsychological Performance was represented by six cognitive 
composite scores that are recommended for categorization of HAND (Antinori et 
al., 2007) and were computed for this analysis: Verbal Fluency/Language, 
Attention/Working Memory, Abstraction/Executive Function, Memory (Learning 
and Recall), Speed of Information Processing, and Motor Skills.  The derivation 
of these scores has been described in detail in a previous report (Castelo et al., 
2007). 
 
SIGNIFICANCE 
As HIV+ positive individuals are living longer lives thanks to improvements 
in cART, the prevalence of HIV-associated neurocognitive disorders is on the 
rise. Cognitive impairments including working memory dysfunction (Chang et al., 
2001; Ernst et al., 2003; Hinkin et al., 2002; Martin et al., 2001; Stout et al., 
1995), difficulty with set-shifting (Sahakian et al., 1995), decreased motor and 
psychomotor speed (Llorente et al., 1998; Villa et al., 1996), increased reaction 
time (Karlsen et al., 1992; Law et al., 1995; Mellgren et al., 2000), and poor 
response inhibition (Hinkin et al., 1999; Llorente et al., 1998) challenge 
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individuals that suffer from HAND. As these types of impairments are associated 
with damage to the fronto-striatal networks (J. R. Berger & Nath, 1997) and HIV 
is known to target the basal ganglia soon after infection (Brew et al., 1995), it has 
been hypothesized that HIV-related cognitive dysfunction is related to 
degeneration that begins prior to the onset of cognitive decline. The included 
studies focus on cognitively asymptomatic HIV+ individuals as characterized by a 
series of neuropsychological tests containing measures sensitive in detecting 
early HIV-related cognitive impairments (Heaton et al., 1995) in conjunction with 
the HIV Dementia Screening Scale (Power et al., 1995) to identify and exclude 
patients with deficits indicative of cognitive impairment (Antinori et al., 2007).  
This research is a valuable extension to the existing body of literature on 
structural changes in HIV as it would be the first to examine all facets of the 
cognitively asymptomatic HIV+ brain – the cortex, WM, and cognitive 
performance together. The experiments additionally investigate the relationship 
between the structural changes that occur in the absence of HAND and the 
already well researched cognitive alterations associated with HIV infection.  
Knowing if and how the changes in the cortex and WM are related is key to 
understanding how HIV compromises the healthy brain. Studying this relationship 
contributes to our understanding of the neurological compromise associated with 
HIV-infection and highlights the brain regions most susceptible in the cognitively 
asymptomatic stages of the disease. Given that nearly 50% of all HIV-infected 
individuals suffer form some form of HAND (Griffin et al., 2015), such knowledge 
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is additionally clinically useful given the continuous development of and need for 
novel antiretroviral medications (Asahchop et al., 2012). 
 
GENERAL METHODS 
 Detailed methods for experiments 1, 2, and 3 are provided in chapters 
two, three, and four, respectively. General methods that pertain to all of the 
experiments are reviewed in the following section.  
 
Participant Recruitment and Screening 
All participants were recruited from various community health centers, 
adult education centers, local universities, and advertisements in neighborhood 
newspapers.  HIV+ patients and control participants were matched for gender, 
age, education, verbal IQ, and handedness. All participants were between the 
ages of 22 and 60 years as previous experiments in our laboratory have found 
that age range to be optimal for study of cognitively asymptomatic HIV. Potential 
participants were given an extensive health questionnaire and screened over the 
telephone. They were invited to take part in the study if all initial inclusion criteria 
as described below were met.  HIV+ patients provided consent for their doctors 
to release medical records of their current CD4 count and plasma viral load.  
Subjects received $50 for approximately one half hour of scanning and $25 for 
approximately two hours of neuropsychological testing.  In addition, HIV+ 
	  23 
patients were provided with radiological films resulting from fifteen additional 
minutes of clinical scans, if requested. 
Exclusion criteria on the health screening questionnaire included a history 
of intravenous drug use, alcohol or drug dependence, history of fungal infection 
of the neurological system, history of psychiatric illness, head injury with loss of 
consciousness exceeding 30 minutes, history of learning disability, history of 
psychosis, a history of neurological illness, or any abnormalities seen on a 
previous MRI or CT of the head. Due to the MRI scanning procedure, participants 
with metal in the body, claustrophobia, or Ménière's disease were also excluded. 
HIV+ patients were excluded if they had previous neurological complications 
associated with HIV infection including cryptococcal meningitis or toxoplasmosis. 
HIV+ participants disclosed diagnosis of HIV infection via self-report based on a 
blood serum assay given by their physician. Medicinal regimen was also 
collected via self-report and confirmed with the patient’s physician when possible.  
All HIV+ participants were given the HIV Dementia Screening Scale (Power et 
al., 1995) in conjunction with a series of neuropsychological tests containing 
measures sensitive in detecting early HIV-related cognitive impairments (Heaton 
et al., 1995) to identify and exclude patients with deficits indicative of 
neurocognitive disorder. 
Participants gave consent to participate in the study with approval from the 
Boston University and Partners Human Research Committees upon arrival at 
Boston University. All participants were provided written informed consent prior to 
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the neuropsychological testing that took place at the Cognitive Neuroimaging 
Laboratory at Boston University. If HIV+ participants were unable to bring current 
immunological information from their physician with them to the testing, they 
were asked to fill out an additional consent form so the information could be 
obtained from their doctor. MRI scanning took place at the Athinoula A. Martinos 
Center for Biomedical Imaging in Charlestown, MA within one month of the 
neuropsychological testing if the participant met all cognitive inclusionary criteria. 
The structural MRI scans necessary for obtaining cortical thickness 
measurements were collected in the same session as the DTI scan.  
 
Neuropsychological Testing 
 All participants underwent a series of neuropsychological tests containing 
measures sensitive in detecting early HIV-related cognitive impairments (Heaton 
et al., 1995). Presence of cognitive impairment, Verbal Fluency/Language, 
Attention/Working Memory, Abstraction/Executive Function, Memory (Learning 
and Recall), Speed of Information Processing, and Motor Skills were examined 
along with estimated pre-morbid verbal intelligence as determined by 
performance on the National Adult Reading Test (Blair & Spreen, 1989). 
Cognitive Impairment Assessment. HIV-positive participants were 
evaluated for HIV-associated neurocognitive disorders (HAND) based on the 
revised research criteria outlined in Antinori et al., 2007. HIV-associated 
asymptomatic neurocognitive impairment (ANI) was documented by performance 
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of at least 1.0 standard deviation (SD) below the mean for appropriate normative 
data on two or more of the composite ability domain scores. HIV-1-associated 
mild neurocognitive disorder (MND) was documented by performance of at least 
1.0 standard deviations (SD) below the mean for appropriate normative data on 
two or more of the composite ability domain scores along with patient self-report 
of reduced mental acuity. HIV-1-associated dementia (HAD) was documented by 
performance of at least 2.0 standard deviations (SD) below the mean for 
appropriate normative data on two or more of the composite ability domain 
scores or greater than 2.5 SD below normative data on 1 domain and greater 
than 1 SD below on another. Additionally, all HIV+ participants were administered 
the HIV Dementia Screening Scale (Power et al., 1995) and excluded from the 
study if they received a score below 10, which is indicative of dementia.  
Verbal Fluency and Language. Participants were administered the Boston 
Naming Test (Kaplan, Goodglass, & Weintraub, 1983) and Category Fluency 
Test (Animals, Spreen and Strauss, 1998) to assess verbal fluency and 
language.  
Attention/ Working Memory. Participants were administered the third 
edition of the Wechsler Adult Intelligence Scale (WAIS-III). The WAIS-III Letter-
Number Sequencing Subtest, WAIS-III Arithmetic Subtest, and WAIS-III Digit 
Span Subtest were used to assess attention and working memory (Wechsler, 
1997). 
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Abstraction/Executive Function. In order assess abstraction and executive 
function, participants were administered the Controlled Oral Word Association 
Test (FAS) (Benton & Hamsher, 1983; Gladsjo et al., 1999), the WAIS-III Matrix 
Reasoning Subtest (Wechsler, 1997), and Trails B of the Trailmaking Test (Army 
Test Battery, 1944; Reitan, 1992). 
Memory (Learning and Recall). The second edition of the California Verbal 
Learning Test (CVLT-II) was administered to participants as it has been shown to 
be sensitive in assessing HIV-related cognitive decline (Peavy et al., 1994) 
through single-item supraspan list learning. CVLT-II Learning trials 1-5 and 
CVLT-II immediate and delayed recall tasks were used to asses memory (Delis, 
Kramer, Kaplan, & Ober, 2000). 
Speed of Information Processing. In order to asses information processing 
speed, participants were administered Trails A of the Trailmaking (Army Test 
Battery, 1944; Reitan, 1992) and the WAIS-III Digit Symbol and Symbol Search 
Subtests,(Wechsler, 1997). 
Motor Speed. Previous studies have documented that the Grooved 
Pegboard is sensitive to HIV-related motor slowing (Davis, Skolasky, Selnes, 
Burgess, & McArthur, 2002) while the Finger Tapping Test from the Halstead-
Reitan Battery is sensitive to HIV-related reaction time increases even in early 
stages of cognitive impairment (Hardy & Hinkin, 2002). Both tests were 
administered to all participants. 
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Depression and Anxiety Assessment. All participants were administered 
the Beck Depression Inventory-II and the Beck Anxiety Inventory (Beck, Brown, 
Berchick, Stewart, & Steer, 1990; Beck, Guth, Steer, & Ball, 1997) to screen for 
mood changes associated with HIV. 
 
General Imaging Methods 
All participants who met the cognitive criteria after neuropsychological 
testing were scanned on a 1.5 Tesla Siemens Sonata System at the Martinos 
Center for Biomedical Imaging in Charlestown, MA. Participants were in the 
scanner for approximately one half hour for T1 and DTI scanning. 
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CHAPTER TWO 
 
Experiment 1: Examination of white matter alterations in cognitively 
asymptomatic individuals with HIV using Diffusion Tensor Imaging 
 
INTRODUCTION 
The human immunodeficiency virus (HIV) enters the CNS and can be 
detected in the brain within two weeks of infection (Krebs, Ross, McAllister, & 
Wigdahl, 2000).  Early studies focused on the impact of the HIV virus on 
subcortical regions (Budka, 1991; Heindel et al., 1994; Navia, 1997), identifying 
the basal ganglia as a particular target (Aylward et al., 1993; J. R. Berger & 
Arendt, 2000; J. R. Berger & Nath, 1997). There is now considerable evidence 
that the other end of the fronto-striatal network is affected as demonstrated by 
volumetric loss within frontal lobe regions (Cohen et al., 2010; Pfefferbaum et al., 
2014; Thompson et al., 2005; Towgood et al., 2012). Additionally, temporal and 
parietal cortical areas are compromised (Becker et al., 2012; Cohen et al., 2010; 
Küper et al., 2011; Pfefferbaum et al., 2014; Thompson et al., 2005; Towgood et 
al., 2012). 
In patients with HIV encephalitis, it has been determined that HIV-infected 
macrophages and multinucleated giant cells target cerebral white matter (WM) 
with regional specificity for the corpus callosum and internal capsule (Gosztonyi 
et al., 1994).  This leads to diffuse WM pallor that becomes more prominent as 
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the disease advances (Price et al., 1988). A number of radiological studies have 
demonstrated overall WM volume loss in HIV (Aylward et al., 1993; J. R. Berger 
& Nath, 1997; Du et al., 2012; Jernigan et al., 1993; Ragin et al., 2004; Stout et 
al., 1998). Using more nuanced magnetic resonance imaging techniques, HIV-
associated changes have been particularly well-documented in the corpus 
callosum (Chang et al., 2008; Filippi et al., 2001; Hoare et al., 2011, 2012; Leite 
et al., 2013; Müller-Oehring et al., 2010; Nir et al., 2014; Pfefferbaum et al., 2009, 
2007; Schulte et al., 2008; Tate et al., 2011; Thurnher et al., 2005; Wright et al., 
2012; Wu et al., 2006) and to a lesser extent in the corona radiate or internal 
capsule/centrum semiovale (Hoare et al., 2012; Leite et al., 2013; Nir et al., 2014; 
Pomara et al., 2001; Wright et al., 2012). 
Diffusion tensor imaging (DTI) allows for excellent distinction among white 
matter structures and provides a means of collecting non-invasive regional 
measures of tissue microstructure. DTI measures the three-dimensional 
magnitude and direction of tissue water mobility, known as self-diffusion.  
Fractional anisotropy (FA), a scalar metric describing the WM microstructure, is a 
measurement calculated from DTI data. In brain WM, the diffusion signal is 
thought to represent diffusion restriction (anisotropy) by the myelinated axonal 
projections due to hydrophobic lipid-based myelin interacting with water.  Lower 
fiber density or decreased myelination results in less tightly-packed fiber bundles. 
In this case, water diffusion is less restricted, lowering FA values (Basser, 1995). 
For HIV positive participants, decreased FA values have been reported across 
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callosal regions (Hoare et al., 2011, 2012; Leite et al., 2013; X. J. Li et al., 2015; 
Müller-Oehring et al., 2010; Nir et al., 2014) and specifically in the genu (Corrêa 
et al., 2015; Filippi et al., 2001; Schulte et al., 2008; V. M. Tang et al., 2015; 
Thurnher et al., 2005) and splenium (Filippi et al., 2001; Wu et al., 2006).  
Recently, reduced FA in the corpus callsoum has been found as early as the first 
100 days of infection (Ragin et al., 2015), while demonstrating a significant 
relationship with duration of infection (Wright et al., 2015).  
Given HIV’s strong affinity for the basal ganglia (J. R. Berger & Arendt, 
2000; Chang et al., 2008; Ragin et al., 2005), it is not surprising that FA 
abnormalities in HIV positive participants have been reported in the fronto-striatal 
network, including the frontal lobes (J. Li et al., 2015; Pomara et al., 2001; Smith 
et al., 2008; Stebbins et al., 2007; Thurnher et al., 2005; Zhu et al., 2013). There 
is mounting evidence that parietal and temporal cortices are affected by HIV-
infection as well (Cohen et al., 2010; Küper et al., 2011; Thompson et al., 2005). 
Altered diffusion measures (Chen et al., 2009) and FA values (Chang et al., 
2008; Gongvatana et al., 2011; J. Li et al., 2015; Stebbins et al., 2007) have 
been reported in the parietal lobes of HIV positive individuals while temporal lobe 
FA increases have been correlated with use of antiretroviral therapies 
(Gongvatana et al., 2011).  A recent longitudinal study of the Simian 
immunodeficiency virus (SIV) also found that decreased FA in inferotemporal 
regions correlated significantly with elevated blood CD4+/CD8+ ratios in primates 
(Z. Tang et al., 2015). 
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The purpose of the present study was to investigate white matter 
alterations in cognitively asymptomatic HIV-positive individuals as compared to 
HIV- control participants. Using a hypothesis driven approach, ROI analysis was 
limited to those WM regions previously shown to be most impacted by HIV 
infection. All participants underwent a neuropsychological battery that followed 
the revised research criteria for the identification of HAND (Antinori et al., 2007). 
The assessment examined the following cognitive domains: verbal 
fluency/language, attention/working memory, abstraction/executive function, 
memory (learning and recall), speed of information processing, and motor skills.  
Based on previous studies, we measured FA within the corpus collosum, internal 
capsule, parietal lobe, parieto-occipital, temporal lobe, and fronto-temporal WM.  
We hypothesized that there are would be evidence of WM injury in all of these 
regions for the cognitively asymptomatic HIV-positive group in the form of 
decreased FA measures.  
 
METHODS 
Participants 
Seventeen cognitively asymptomatic HIV+ individuals without HAND as 
determined by widely accepted neuropsychological performance guidelines 
(CAHIV+), seventeen HIV-negative control participants matched for age, 
education, and verbal IQ, (HIV-) and six HIV-positive individuals with measurable 
cognitive impairment (HAND) for secondary analyses were analyzed in this 
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study. All participants provided informed consent, following procedures that were 
approved by the Partners Human Research Committee, which oversees human 
research at the Anthinoula A. Martinos Center for Biological Imaging (site of DTI 
imaging) and Boston University (site of neuropsychological testing and data 
analysis) institutional review board (IRB). Participants were recruited via 
advertisements in local newspapers and flyers posted at community health 
centers.  Women were not excluded from the study, however due to the 
demographics of the local HIV population, all participants that met our inclusion 
criteria were men. Participants represented Caucasian, African American, Asian, 
and Hispanic ethnicities. Exclusion criteria for all participants included a history of 
intravenous drug use, alcohol or drug dependence, history of fungal infection of 
the neurological system, history of psychiatric illness other than major 
depression, head injury with loss of consciousness exceeding 30 minutes, history 
of learning disability, history of psychosis, a history of neurological illness, or any 
abnormalities seen on a previous MRI or CT of the head. Participants with metal 
in the body, claustrophobia, or Meniere's disease were also excluded. Additional 
exclusionary criteria for HIV-positive participants included any previous HIV-
related Central Nervous System infections secondary to immunodeficiency. Each 
participant underwent neuropsychological testing (described below), followed by 
the MRI protocol (described below) within one month. The cognitively 
asymptomatic HIV+ and HIV- groups were matched for age, education, and pre-
morbid verbal intelligence as determined by performance on the National Adult 
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Reading Test (Blair & Spreen, 1989) as summarized in Table 2.1. The smaller 
cognitively symptomatic HIV+ HAND group was subsequently matched on these 
same measures with a subset of the cognitively asymptomatic HIV+ population 
as summarized in Table 2.2.  
 
Immunological information 
 CD4 cell count (cells/mL), plasma viral load (log RNA/mL), and 
medication status were obtained, with consent, from participant medical records. 
Medication status was characterized as HAART (two nucleoside reverse 
transcriptase inhibitors (NRTIs) and a protease inhibitor, or two NRTIs and a 
nonnucleoside reverse transcriptase inhibitor (NNRTI), non-HAART, or none. 
CD4 counts were unavailable for 4 participants and plasma viral load was 
unavailable for 5 participants. CD4 counts, plasma viral loads, and percentage of 
patients in each medication class is summarized in Table 1 for cognitively 
asymptomatic HIV-positive subjects and in Table 2 for HIV-positive subject with 
HAND. 
 
Neuropsychological evaluation 
Within one month of the MRI, all subjects underwent a neuropsychological 
battery that followed the revised research criteria for the identification of HAND 
(Antinori et al., 2007). Verbal/language, attention/working memory, 
abstraction/executive function, memory (learning and recall), speed of 
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information processing, and motor skills were examined as well as performance 
on the National Adult Reading Test (Blair & Spreen, 1989) to estimate verbal 
intelligence. Additionally, all HIV-positive participants were administered the HIV 
Dementia Scale (Sacktor et al., 2005). The following six cognitive domain 
composite scores were computed for this analysis: verbal fluency and language 
(Boston Naming Test, BNT (Kaplan et al., 1983); Category Fluency Test 
(Animals (Spreen & Strauss, 1998))), attention/ working memory (WAIS-III Letter-
Number Sequencing Subtest, WAIS-III Arithmetic Subtest, WAIS-III Digit Span 
Subtest (Wechsler, 1997)), abstraction/ executive function (Controlled Oral Word 
Association Test (FAS) (Benton & Hamsher, 1983; Gladsjo et al., 1999); WAIS-III 
Matrix Reasoning Subtest (Wechsler, 1997), Trailmaking Test Part B (Army Test 
Battery, 1944; Reitan, 1992)), memory learning and recall (California Verbal 
Learning Test I learning trials 1-5, immediate and delayed recall, (Delis et al., 
2000), speed of information processing (Trailmaking Test Part A, (Army Test 
Battery, 1944; Reitan, 1992)) and WAIS-III Digit Symbol and Symbol Search 
Subtests, (Wechsler, 1997)), and motor speed (Grooved Pegboard ((Davis et al., 
2002)) and Finger Tapping Tests dominant and nondominant (Hardy & Hinkin, 
2002). Cognitive composite scores were computed using previously published 
methods from our group (Castelo, Courtney, Melrose, & Stern, 2007). Briefly, all 
raw scores were converted to z scores based on published normative data. The z 
scores for the individual tests from each cognitive domain were then averaged to 
compute a single composite score per person.  
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HIV-positive participants were evaluated for HIV-associated 
neurocognitive disorders (HAND) based on the revised research criteria outlined 
in Antinori et al., 2007. HIV-associated asymptomatic neurocognitive impairment 
(ANI, n=2) was documented by performance of at least 1.0 standard deviations 
(SD) below the mean for appropriate normative data on two or more of the 
composite ability domain scores. HIV-1-associated mild neurocognitive disorder 
(MND, n=1) was documented by performance of at least 1.0 standard deviations 
(SD) below the mean for appropriate normative data on two or more of the 
composite ability domain scores along with patient self-report of reduced mental 
acuity. HIV-1-associated dementia (HAD, n=3) was documented by performance 
of at least 2.0 standard deviations (SD) below the mean for appropriate 
normative data on two or more of the composite ability domain scores or greater 
than 2.5 SD below normative data on 1 domain and greater than 1 SD below on 
another. Collectively these 6 subjects formed an exploratory analysis group, 
HAND, for ROI comparison with the remainder of HIV-positive subjects classified 
as cognitively asymptomatic (CAHIV+).  
 
MRI scan protocol 
Whole-head, high-resolution DTI scans (Siemens, Erlangen Germany, 1.5 
T Sonata System; TR=14.4s, TE=81ms, slice thickness = 2mm isotropic, 60 
slices total, acquisition matrix 128mm x 128mm (FOV=256mm x 256mm), 5/8 
partial Fourier, 6 averages, 6 non-collinear directions with b-value = 700s/mm2, 
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and 1 image, the T2 weighted ‘lowb’ image, with b-value = 0s/mm2) were 
obtained for each participant. DTI acquisition utilized an eddy-current suppressed 
echo pulse sequence to significantly reduce distortions (Reese, Heid, Weisskoff, 
& Wedeen, 2003). 
 
DT Image analysis 
 Custom diffusion tools developed at the Martinos Center for Biomedical 
Imaging were used in conjunction with software available as part of the 
Freesurfer (http://surfer.nmr.mgh.harvard.edu) and FSL (http://fmrib.ox.ac.uk/fsl) 
processing streams for image processing and statistical analysis. A multistep 
pre-processing procedure was performed on the DTI data for each participant to 
correct for motion and distortion, calculate FA maps, and spatially transform T2-
weighed lowb volumes to a lowb template in normalized space based on 
MNI/Talairach space developed at the Martinos Center using similar diffusion 
sets. FA maps were then resampled using the newly created lowb transform.  
T2-weighed lowb structural volumes were collected using the same 
sequence parameters as the directional volumes. This allowed each directional 
volume from the diffusion dataset to be resampled to the lowb image to correct 
for eddy current distortion or participant movement in the scanner. This was 
achieved using the FMRIB’s Linear Image Registration Tool (FLIRT) as a part of 
the FSL analysis stream. The diffusion tensor was then calculated for each voxel 
in the volume using a least-squares fit to the diffusion signal (Basser, Mattiello, & 
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LeBihan, 1994). FA maps were then acquired from the calculated diffusion tensor 
(Pierpaoli & Basser, 1996). This analysis stream replicated methods previously 
used to study WM alterations associated with age (Salat, Tuch, Greve, et al., 
2005; D. H. Salat, Tuch, Hevelone, et al., 2005), Huntington’s Disease (Rosas et 
al., 2006), and cerebral amyloid angiopathy (Salat et al., 2006). 
 
Whole Brain Maps 
Exploratory voxel based analyses were performed to examine the regional 
distribution of HIV-related FA alterations and to guide additional ROI analyses. 
Spatially normalized FA maps were smoothed using a 3D spatial smoothing filter 
with a full width half maximum of 4 mm and compared by voxel based t-test 
between the combined HIV+ (asymptomatic and HAND) and HIV- groups. As 
there is a potential for misalignment in voxel-based volume registration, 
particularly in patient populations with atrophy, we excluded all voxels outside of 
WM thresholds set by the trace volume and visually examined each transformed 
volume carefully as explained in detail elsewhere (Salat, Tuch, Greve, et al., 
2005; Salat, Tuch, Hevelone, et al., 2005). Since misregistrations could 
potentially alter the results, these maps should be considered exploratory and 
are secondary to the ROI analyses described below. 
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Regional Analysis 
We measured FA in seven ROIs: left, right, and central posterior corpus 
callosum, central anterior callosum, left and right internal capsule, left and right 
parietal lobe white matter (WM), left and right parieto- occipital WM, 
frontotemporal WM, and left and right temporal lobe WM. Uniform ROIs (squares, 
9 voxels in size) were manually inserted on the spatially normalized lowb volume 
for each participant using the Tkmedit function in the Freesurfer package 
(Illustrated in Figure 2.3). Spatial normalization was achieved by creating a lowb 
template. First, FSL registration tools were used to perform a mutual information 
cost function based registration between each participant’s lowb volume and the 
T2 template provided by the Montreal Neurological Institute (MNI; Montreal, 
Canada).  Next, the normalized volumes were averaged.  Each ROI was placed 
in a region previously associated with HIV-related neurodegeneration using a 
standardized placement procedure. This uniform square avoided arbitrary sizes 
of ROIs across participants.  ROI analyses were performed blind to participant 
HIV-status.  By studying the FA and tensor maps for each participant, anatomical 
boundaries were defined for ROI placement in an effort to stay within 
homogeneous regions of WM fibers and to avoid sampling voxels that included 
gray matter or cerebral spinal fluid.  Left and right posterior corpus callosum 
ROIs were defined on the axial plane by placing the square where the splenium 
meets the forceps major in each hemisphere. A central posterior callosum ROI 
was centered in the splenium on the axial plane. A central anterior callosum ROI 
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was placed in the same axial slice in the center of the genu. Left and right 
internal capsule ROIs were defined on the axial plane, lateral to the center of the 
thalamus. Left and right parietal ROIs were defined in deep WM (at least 3mm 
from the gray matter/white matter border) in the center of the axial plane just 
above the corpus callosum. Left and right parieto-occipital ROIs were defined in 
deep WM in the axial plane of the posterior corpus callosum. Frontotemporal 
ROIs were defined in the sagittal plane centered and just superior to the corpus 
callosum. Left and right temporal ROIs were placed in the deep WM in the 
coronal plane just lateral to the inferior horn of the lateral ventricle. 
 
Statistical Analysis 
The HIV- (n=17) and cognitively asymptomatic HIV+ (n=17) groups were 
matched with respect to age, education, estimated verbal I.Q., and handedness 
(see Table 1). For additional analyses, the cognitively symptomatic HIV+ group 
(HAND, n=6) was matched to a subset of the asymptomatic HIV+ participants 
(n=8) with respect to age, education, estimated verbal I.Q., and CD4 count, viral 
load, and HIV Dementia Scale score (see Table 2). We conducted independent-
sample t tests to examine between-group differences in FA for the HIV- and 
cognitively asymptomatic HIV+ groups as well as the cognitively asymptomatic 
HIV+ subset and HAND groups.  
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RESULTS  
Visualization of exploratory global FA maps indicated increased FA in a 
combined group of all HIV positive participants (HIV+ and HAND) across several 
regions including the posterior callosum and temporal lobes as well as regional 
FA decreases in the parietal lobe (see Figure 2.1) when compared to the HIV- 
group. Apparent FA increases on global exploratory maps for all HIV+ in the PCC 
can be viewed as both group and individual maps in Figure 2.2. Regional FA 
differences were highly significant in the frontotemporal ROI (p=.00008) where 
FA was increased for the CAHIV+ group as compared to HIV-. The left, right, and 
total posterior callosum ROIs were also significant (p=.04, .04, and .02, 
respectively) for increased FA in the CAHIV+ group as compared with HIV-. The 
left and right parietal ROIs showed a significant decrease in FA (p=.04, .03, 
respectively) for CAHIV+ compared to HIV-. All regional FA differences are 
illustrated in Figure 2.3. No significant FA differences were identified between the 
HAND group and matched subset of CAHIV+ individuals. Individual FA values for 
the highly significant frontotemporal ROI are illustrated in Figure 2.4.  
 
DISCUSSION 
The current study used DTI methods to detect subtle WM changes 
associated with HIV infection in a group of patients with well-characterized 
cognitive status. The cognitively asymptomatic HIV-positive individuals 
demonstrated higher FA values in the frontotemporal region and posterior 
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callosum, but lower FA values in parietal WM when compared with the control 
group. When combining participants from both HIV-positive asymptomatic and 
HAND groups, we detected negative associations between left posterior 
callosum FA and two domains of cognition.   
 The most significant finding for this study was increased FA in the 
frontotemporal region for HIV positive participants without HAND when compared 
to HIV negative individuals. This finding runs contrary to our initial hypothesis and 
was somewhat unexpected given the nature of anisotropic diffusion. In brain WM, 
the diffusion signal is thought to represent diffusion restriction (anisotropy) by the 
myelinated axonal projections due to hydrophobic lipid-based myelin interacting 
with water.  Lower fiber density or decreased myelination would result in less 
tightly packed fiber bundles, and thus, water diffusion would be less restricted, 
lowering FA values (Basser, 1995). While this is not the first study to report 
increased FA in an HIV positive population (Gongvatana et al., 2011; Hoare et 
al., 2011, 2012; Pomara et al., 2001; Smith et al., 2008; Stebbins et al., 2007; 
Stubbe-Drger et al., 2012; Thurnher et al., 2005), it is generally assumed that FA 
will decrease with HIV-associated WM damage. One interpretation is that the FA 
increase reflects a loss of regional white matter complexity (Stebbins et al., 2007) 
from damaged crossing and nonparallel WM fibers. With parallel fibers left 
preserved, increased FA would occur. In a combined gross anatomical and 
morphometric study of the corpus callosum in HIV-infected brains, swelling of 
axons and myelin sheaths was seen along with diminished myelin thickness in 
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other regions (Wohlschlaeger, Wenger, Mehraein, & Weis, 2009). Diminished 
myelin thickness would likely result in less tightly packed fiber bundles while 
swelling could potentially spread out WM tracts, decreasing the complexity and 
resulting in higher FA values for our CAHIV+ group. Other studies have reported 
elevated gray matter volumes for HIV+ individuals (Castelo et al., 2007; Jernigan 
et al., 2011) giving the possible explanation of tissue swelling resulting from 
immune reactivation. It is also important to note a potential role of antiretroviral 
medications as a cause of increased FA in this region. Gongvatana and 
collegues (2011) found that HIV patients undergoing antiretroviral treatment 
exhibited higher anisotropy specifically in the temporal lobe when compared to 
patients not on a medicinal regimen.  
While frontostriatal compromise has been well documented in HIV (J. R. 
Berger & Nath, 1997), recent evidence suggests that temporal cortices are 
affected both functionally and structurally by HIV-infection as well. An fMRI 
investigation of HIV-positive patients during an episodic encoding task 
demonstrated reduced signal intensity in the right medial temporal lobe when 
compared to an HIV- control group (Castelo, Sherman, Courtney, Melrose, & 
Stern, 2006). Structurally, one study documented loss of gray matter in the 
anterior cingulate and temporal cortices for HIV positive individuals with 
neurocognitive impairment (Küper et al., 2011). Another showed an association 
between gray matter loss in the anterior temporal lobe and neuropsychological 
performance (Becker et al., 2012). It is unsurprising that underlying temporal lobe 
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white matter would be altered with HIV-infection in the absence of cognitive 
impairment. Increased temporal lobe FA has previously been documented in two 
other DTI studies of HIV, for HIV positive individuals with significant depressive 
symptoms (Smith et al., 2008) and those undergoing antiretroviral treatment 
(Gongvatana et al., 2011). 
Additional significant FA changes were observed in the posterior corpus 
callosum and parietal lobe WM for our cognitively asymptomatic HIV+ group as 
compared to HIV- participants. Several imaging studies have reported WM 
compromise in the corpus callosum of HIV patients (Chang et al., 2008; Corrêa 
et al., 2015; Filippi et al., 2001; Hoare et al., 2011, 2012, 2015; Leite et al., 2013; 
J. Li et al., 2015; Müller-Oehring et al., 2010; Nir et al., 2014; Pfefferbaum et al., 
2009, 2007; Ragin et al., 2015; Schulte et al., 2008; V. M. Tang et al., 2015; Tate 
et al., 2011; Thurnher et al., 2005; Wright et al., 2015, 2012; Wu et al., 2006). 
Additionally, correlations between corpus callosum alterations and measures of 
cognitive health have been reported (Hoare et al., 2012; Nir et al., 2014; Schulte 
et al., 2008; V. M. Tang et al., 2015; Wu et al., 2006; Zhu et al., 2013). The 
current study demonstrated similar findings with the left, right, and total posterior 
corpus callosum ROIs showing significant increased FA in the HIV+ group as 
compared with HIV-. As with the increased FA seen in the frontotemporal ROI, 
this may be attributed to a loss of regional white matter complexity.   
While FA increases were noted in the posterior callosum and 
frontotemporal WM, left and right parietal lobe ROIs showed a significant 
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decrease in FA for the cognitively asymptomatic HIV+ group compared to HIV-. 
Previous studies have reported altered diffusion measures (Chen et al., 2009) 
and both reduced (Chang et al., 2008; X. J. Li et al., 2015) and increased 
(Gongvatana et al., 2011; Stebbins et al., 2007) FA values in the parietal lobes of 
HIV positive individuals. In a study examining patients at baseline and a one-year 
follow up, cognitive change in HIV patients as measured by a global deficit score 
correlated with parietal lobe FA values (Chang et al., 2008). Additionally, 
neuropsychological evaluations have shown HIV-related impairment in a parietal-
dependent mental rotation tasks (Olesen et al., 2007; Weber, Woods, Cameron, 
Gibson, & Grant, 2010) while an fMRI investigation demonstrated posterior 
parietal hyperactivity for HIV+ individuals during an episodic encoding task 
(Castelo et al., 2006).  
It is important to note the limitations of this study. First, due to the small 
sample size and resultant limited power, the results have not been corrected for 
multiple comparisons. This limitation is offset by restricting our analysis to a priori 
regions previously associated with HIV-related cognitive decline. It is also worth 
noting that our results are consistent with prior DTI studies investigating regional 
HIV-associated alterations (Gongvatana et al., 2011; Hoare et al., 2012; Nir et 
al., 2014; Schulte et al., 2008; Smith et al., 2008; V. M. Tang et al., 2015; Wu et 
al., 2006; Zhu et al., 2013). An additional limitation is that while exclusion criteria 
for all participants included a history of intravenous drug use, alcohol or drug 
dependence, some subjects included in our study had a history of recreational 
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illicit drug use, and it has been documented that co-morbid substance abuse 
(Chang, Ernst, Speck, & Grob, 2005; Jernigan et al., 2005) and alcoholism 
(Pfefferbaum et al., 2007) may influence HIV-associated brain alterations. Finally, 
in terms of methodological considerations, we utilized a balanced echo sequence 
to reduce eddy current distortion and post-processing was used to reduce 
residual distortion and motion. However, echo-planar scans are susceptible to 
additional distortions such as reduced signal (Jezzard & Clare, 1999). In an 
attempt to limit such distortions, regions were only sampled within deep WM.  
Despite these limitations, our data suggest that increases in frontotemporal and 
posterior corpus callosum FA and decreases in parietal lobe FA occur in HIV 
patients, even those that are cognitively asymptomatic.  
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Table 2.1. Subject demographics for cognitively asymptomatic HIV-positive 
participants (CAHIV+) and HIV- control participants (HIV-) presented as means 
with standard deviations. P-values reflect results of independent sample t-tests. 
NART: National Adult Reading Test. 
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 HIV- CAHIV+ p-
values 
N 17 17 N/A 
Age 42.35 ± 9.18 (31-54) 38.17 ± 10.74 (22-
59) 
0.50 
Education 
(years) 
16.06 ± 2.01 (12-18) 15.33 ± 1.97 (12-18) 0.48 
NART Estimated  
Verbal IQ 
119.5 ± 4.27  
(107.34-126.03) 
117.5 ± 7.3  
(106.45-126.92) 
0.13 
 
Handedness 
 
94% Right 
 
94% Right 
 
N/A 
 
†CD4 count at 
testing 
 
N/A 
 
 
688.6 ± 309.9 (249-
1433) 
 
N/A 
 
†Viral load at 
testing 
(copies/µl) 
 
N/A 
 
6.27 ± 11.09 (<.05-
43.8) 
 
N/A 
 
HIV Dementia 
Screening Score 
 
N/A 
 
15.2 ±  1.17 (13-16) 
 
N/A 
 
HIV Medications 
 
N/A 
 
9 HAART, 1 non-
HAART, 7 none 
 
N/A 
 
† Information not available for two participants. 	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Table 2.2. Subject demographics for HIV-positive participants with HIV-
associated neurocognitive disorders (HAND) as compared to a subset of 
cognitively asymptomatic HIV+ participants (CAHIV+) presented as means with 
standard deviations. P-values reflect results of independent sample t-tests. 
NART: National Adult Reading Test, ANI: asymptomatic neurocognitive 
impairment, MND: mild neurocognitive impairment, HAD: HIV-associated 
dementia. 
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 HAND CAHIV+ p-
values 
N 6 8 N/A 
Age 43 ± 7.72 (31-51) 41.4 ± 7.63 (34-54) 0.66 
Education 
(years) 
13.5 ± 1.51 (12-16) 14 ± 2 (12-16) 0.27 
 
NART Estimated 
Verbal IQ 
 
100.96 ± 5.38  
(93.99-108.23) 
 
104.85 ± 10.37  
(86.87-110.9) 
 
0.21 
 
Handedness 
 
100% Right 
 
75% Right 
 
N/A 
 
†CD4 count at 
testing 
 
646.5 ± 464.23  
(132-1240) 
 
 
621.22 ± 290.63  
(249-1064) 
 
0.92 
 
§Viral load at 
testing 
(copies/µl) 
 
248.23 ± 425.89  
(<.075-740) 
 
2.87 ± 4.46  
(<.075-6.99) 
 
0.17 
 
HIV Dementia 
Scale Score 
 
14.58 ± 1.5 (12-16) 
 
15.4 ±  1.34 (13-16) 
 
0.54 
 
HIV Medications 
 
3 HAART, 1 non-
HAART, 2 none 
 
4 HAART, 1 non- 
HAART, 3 none 
 
N/A 
 
HAND 
Classification 
 
2 ANI, 1 MND, 3 HAD 
 
N/A 
 
N/A 	  
† Information not available for two HAND, 2 HIV+. 
§ Information not available for three HAND, 2 HIV+. 	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Figure 2.1. Global fractional anisotropy maps for all HIV+ and HIV- subjects. 
Yellow indicates areas of increased FA for the HIV+ as compared to HIV-. Blue 
indicates areas of decreased FA for HIV+ as compared to HIV-. 
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Fig. 2.2. Illustration of increased fractional anisotropy in the posterior corpus 
callosum for all HIV+ subjects. The images on the left are averages of all HIV- 
(top) and HIV+ (bottom) participants. Those on the right are FA maps for 
individual subjects.  
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Fig. 2.3. Comparison between cognitively asymptomatic HIV+ participants 
(CAHIV+) and seronegative control participants (HIV-) in a priori regions of 
interest previously associated with HIV-related neurodegenerative disease. (A) 
Localization of regions of interest. (B) Bar graphs show mean white matter 
fractional anisotropy and standard error within each ROI.  
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* denotes a p-value <.05. ** denotes a p-value of 0.00008. 
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Fig. 2.4. Scatterplot illustrating the individual frontotemporal region white matter 
fractional anisotropy values for HIV- participants, cognitively asymptomatic HIV-
positive individuals (CAHIV+), and HIV-positive participants with HIV-associated 
cognitive disorder (HAND). 
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CHAPTER THREE 
 
Experiment 2: Examination of structural changes in the cerebral cortex in 
cognitively asymptomatic individuals with HIV using cortical thickness 
measurements calculated from Magnetic Resonance Imaging scans 
 
INTRODUCTION 
Previous studies have demonstrated that the human immunodeficiency 
virus (HIV) predominantly affects subcortical regions of the brain with particular 
affinity for the basal ganglia and white matter pathways (J. R. Berger & Nath, 
1997; Budka, 1991; Navia, 1997). However, the occurrence and onset of damage 
to cortical regions and the specific regional patterns of cortical alteration is still 
being defined.  
The earliest imaging studies utilized qualitative clinical definitions of 
atrophy as defined by radiologists in which sulcal width was examined in different 
stages of HIV infection across the cortex. These studies reported a greater 
proportion of participants with an AIDS diagnosis as having enlarged sulci when 
compared to HIV- or pre-AIDS HIV+ participants (Harrison et al., 1998; 
Poutiainen et al., 1993), overall cortical atrophy being associated with HIV 
encephalitis (Chrysikopoulos et al., 1990; Post et al., 1988; Wiley et al., 1991), 
and greater gray matter volume loss related to more advanced stages of HIV 
illness as defined by the Centers for Disease Control (CDC) (Di Sclafani et al., 
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1997).  One investigation reported pronounced atrophy localized within the 
temporal lobes of HIV+ participants (Elovaara et al., 1990). However, no cortical 
atrophy was reported for evaluation including comparatively large group of 233 
HIV+ participants with mild cognitive impairment (Dooneief et al., 1992).  
While MR imaging techniques and quantitative data analysis tools have 
emerged, questions still remain regarding the regional pattern and onset of HIV-
related alterations in the cortex. One such volumetric report demonstrated that 
deceased HIV+ participants had decreased cortical volumes as compared to a 
HIV- control group (Archibald et al., 2004). Studies examining regional volume 
loss have reported significant reduction of posterior gray matter in HIV+ 
participants with dementia as compared to HIV+ and HIV- individuals without 
dementia (Aylward et al., 1995). A more rapid loss of cortical tissue was 
additionally documented in both medically asymptomatic and symptomatic HIV+ 
men compared to a seronegative group (Stout et al., 1998). More recently, local 
cortical thinning has been reported in the frontal and temporal lobes of HIV+ 
individuals and associated with low CD4 count (Thompson et al., 2005) and high 
HIV DNA levels in peripheral blood (Kallianpur et al., 2012) while brain volume 
abnormalities have been associated with HIV-related medical factors such as 
nadir CD4 count, history of an AIDS-defining event, age at infection, and clinical 
staging (Pfefferbaum et al., 2012). Another investigation found no differences in 
cortical thickness between HIV-infected individuals with and without cognitive 
deficits and matched control participants.  
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There is an extensive body of literature suggesting that fronto-striatal 
dysfunction is associated with HIV (Chang et al., 2001; Ernst et al., 2003; Hinkin 
et al., 2002; Llorente et al., 1998; Martin et al., 2001; Sahakian et al., 1995; Stout 
et al., 1995; Villa et al., 1996). Poorer performance on neuropsychological 
measures has correlated both with reduced brain regional brain volumes in HIV+ 
individuals (Becker et al., 2012; Küper et al., 2011; Paul et al., 2008; Thompson 
et al., 2005) and enlarged subcortical structures (Castelo et al., 2007). However, 
it is unknown whether this degeneration occurs in the absence of HAND.  
The purpose of the present study was to investigate cortical thickness in 
cognitively asymptomatic HIV-positive individuals as compared to HIV- control 
participants. Using a hypothesis driven approach, ROI analysis was limited to 
those cortical regions previously shown to be most impacted by HIV infection via 
exploratory analyses. All participants underwent a neuropsychological battery 
that followed the revised research criteria for the identification of HAND (Antinori 
et al., 2007). The assessment examined the following cognitive domains: verbal 
fluency/language, attention/working memory, abstraction/executive function, 
memory (learning and recall), speed of information processing, and motor skills.  
We used automated surface reconstruction procedures to measure the thickness 
of the cerebral cortex from high-resolution magnetic resonance (MR) images 
(Fischl and Dale, 2000). This quantitative method allowed us to identify regional 
cortical changes, providing regionally specified measurements of atrophy across 
the entire mantle.  Based on previous research and exploratory whole brain 
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maps, we measured cortical thickness within the cingulate gyrus, superior 
temporal gyri, and middle occipital gyrus. We hypothesized that there would be 
reduced regional cortical thickness within in all of these regions for the HIV-
positive group without HAND when compared to the HIV- group. 
 
METHODS 
Participants.  
Nineteen HIV-negative (HIV-) participants and 29 HIV-positive participants 
were analyzed in this study.  For the HIV+ participants, 22 were cognitively 
asymptomatic (CAHIV+), and 7 participants were cognitively symptomatic using 
the criteria for HIV-associated neurocognitive disorders (HAND). All participants 
provided informed consent, following procedures that were approved by the 
Partners Human Research Committee, which oversees human research at the 
Anthinoula A. Martinos Center for Biological Imaging (site of DTI imaging) and 
Boston University (site of neuropsychological testing and data analysis) 
institutional review board (IRB). Participants were recruited via advertisements in 
local newspapers and flyers posted at community health centers.  Women were 
not excluded from the study, however due to the demographics of the local HIV 
population, all participants that met our inclusion criteria were men. Participants 
represented Caucasian, African American, Asian, and Hispanic ethnicities. 
Exclusion criteria for all participants included a history of intravenous drug use, 
alcohol or drug dependence, history of fungal infection of the neurological 
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system, history of psychiatric illness other than major depression, head injury 
with loss of consciousness exceeding 30 minutes, history of learning disability, 
history of psychosis, a history of neurological illness, or any abnormalities seen 
on a previous MRI or CT of the head. Participants with metal in the body, 
claustrophobia, or Meniere's disease were also excluded. Additional exclusionary 
criteria for HIV-positive participants included any previous HIV-related Central 
Nervous System infections secondary to immunodeficiency. Each participant 
underwent neuropsychological testing (described below), followed by the MRI 
protocol (described below) within one month. The cognitively asymptomatic HIV+ 
and HIV- groups were matched for age, education, and pre-morbid verbal 
intelligence as determined by performance on the National Adult Reading Test 
(Blair & Spreen, 1989) as summarized in Table 3.1. The smaller cognitively 
symptomatic HIV+ HAND group was subsequently matched on these same 
measures with a subset of the cognitively asymptomatic HIV+ population as 
summarized in Table 3.2.  
 
Immunological Information. 
CD4 cell count (cells/mL), plasma viral load (log RNA/mL), and medication 
status were obtained, with consent, from participant medical records. Medication 
status was characterized as HAART (two nucleoside reverse transcriptase 
inhibitors (NRTIs) and a protease inhibitor, or two NRTIs and a nonnucleoside 
reverse transcriptase inhibitor (NNRTI), non-HAART, or none. CD4 counts and 
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plasma viral loads were unavailable for 2 CAHIV+ participants. CD4 counts, 
plasma viral loads, and percentage of patients in each medication class is 
summarized in Table 3.1 for cognitively asymptomatic HIV-positive subjects and 
in Table 3.2 for HIV-positive subject with HAND. 
 
Magnetic Resonance Imaging.  
High-resolution T1-weighted MPRAGE scans were obtained on a 1.5 
Tesla Siemens Sonata scanner (Imaging parameters: resolution 1.3 x 1.3 x 1 
mm, echo time (TE) = 3.2 or 3.0 ms, repetition time (TR) = 2730 ms, inversion 
time (TI) = 1000 ms, flip angle = 7o, field of view (FOV) = 256x256 mm, matrix = 
192x256). These parameters were empirically optimized for high gray 
matter/white matter and gray matter/cerebral spinal fluid contrast. Two scans 
were collected, motion corrected, and averaged to create a single high-signal, 
high-contrast volume for each participant. Head motion was minimized using 
padding. 
 
Image Analysis. 
 
The averaged volume was used to create representations of the gray 
matter/white matter boundary for each participant (Dale et al., 1999; Dale & 
Sereno, 1993). This surface was then deformed outward to locate the gray 
matter/cerebrospinal fluid border to produce measures of cortical thickness with 
sub-millimeter accuracy (Fischl & Dale, 2000). This method uses both intensity 
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and continuity information in the creation of surface boundaries. Additionally, 
both sets of surfaces were automatically topologically corrected (Fischl, Liu, & 
Dale, 2001). Cortical thickness measurements were calculated by measuring the 
distance between gray matter/white matter and gray matter/cerebrospinal fluid 
surfaces at each surface vertex across the cortical mantle and then mapped onto 
the inflated surface of each participant (Dale & Sereno, 1993; Fischl, Sereno, & 
Dale, 1999). This allowed for visualization of the data across the entire cortical 
surface (i.e. sulci and gyri) without being obscured by folds in the cortex. Each 
participant’s reconstructed brain was registered to an average spherical surface 
representation that optimally aligned sulcal and gyral patterns across participants 
for interparticipant registration (Fischl, Sereno, & Dale, 1999; Fischl, Sereno, 
Tootell, & Dale, 1999). The maps were then smoothed using a circularly 
symmetric Gaussian kernel across the surface with a standard deviation of 7 
mm. This technique has been validated by direct comparison with measurements 
made on postmortem brains (Rosas et al., 2002) and provides comparable data 
to manually drawn regions of interest (Kuperberg et al., 2003; Salat et al., 2004).  
 
Exploratory whole brain analyses.  
We first created exploratory whole brain surface maps of HIV-associated 
cortical thickness alterations in a subset of 20 participants (10 HIV+, 10 HIV-). 
These analyses were considered exploratory because prior studies have noted 
the potential for misalignment in voxel-based volume registration, particularly for 
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images where atrophy is expected (Jernigan, Gamst, Fennema-Notestine, & 
Ostergaard, 2003). While each image went through the detailed registration 
process described above and was carefully inspected visually, it is still possible 
that misregistrations can contribute to the presented results. Therefore, these 
maps are considered secondary to the ROI analyses.  
 
Regional analyses. 
All ROIs were created using an automated parcellation technique based 
on a manually labeled training set using cortical folds for regional boundaries 
(Fischl et al., 2004). Our preliminary whole brain maps (described above) 
suggested that regions spanning the temporal and occipital lobes along with 
smaller areas in the parietal and frontal lobes were most thinned in the group of 
HIV+ individuals. We obtained measures from these same regions in an 
independent sample of 39 participants (20 HIV+, 19 HIV-) to determine whether 
the effect was replicable. The results were similar across the two independent 
analyses. Additionally, with the exception of the occipital cortex, these same 
regions have been previously associated with HIV-associated atrophy (Becker et 
al., 2012; Thompson et al., 2005). Therefore, thickness was analyzed in 
anatomical parcellations encompassing these regions for the final reported 
analysis of CAHIV+ as compared to HIV- individuals. Anatomical parcellations of 
theses ROIs are shown in Figure 3.2. We conducted independent-sample t tests 
to examine between-group differences in cortical ROIs. 
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RESULTS 
Exploratory whole brain analyses.  
The preliminary whole brain surface map of HIV-associated cortical 
thickness alterations for 49 participants (30 HIV+, including both cognitively 
asymptomatic and symptomatic and 29 HIV-) highlighted regionally variable 
reduced thickness with strongest statistical effects in the temporal and occipital 
lobes (Figure 3.1). 
 
Global Thickness. 
 There were no significant global or hemispheric thickness differences 
between the CAHIV+ participants and matched HIV- individuals (demographics 
listed in Table 3.1) or between HAND patients and the subset of CAHIV+ 
participants (demographics listed in Table 3.2). 
 
Regions of Interest.  
Mean cortical thickness measurements (in mm) for the ROIs showing 
statistically significant between-group thickness differences are presented in 
Table 3.3a. Two regions showed significant statistical differences between the 
CAHIV+ and HIV- groups – the superior temporal gyrus (STG) and the inferior 
occipital gyrus. A mean reduction of 6.0% thickness was calculated in the planum 
polare region of the STG while a mean increase of 16.7% thickness was 
calculated in the inferior occipital gyrus.  
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Additional comparisons between HAND patients and the matched subset 
of the CAHIV+ participants, yielded significant reduced thickness measures in the 
STG, cingulate sulcus, and additional parietal ROIs. These results are presented 
in Table 3.3b. 
 
DISCUSSION 
The goal of this study was to examine HIV-related cortical thickness 
alterations using a quantitative, automated computational approach that 
estimates thickness across the entire cortical mantle using high-resolution MR 
images (Fischl & Dale, 2000). The results demonstrate that regional HIV-
associated cortical alterations occur in the cingulate sulcus, temporal, occipital, 
and parietal lobes. Importantly, these data suggest that degenerative processes 
occur in the cortex in the absence of HAND and that these processes are 
regionally specific. 
Our findings of reduced regional thickness in the temporal lobe for 
CAHIV+ participants and temporal, parietal, and cingulate cortices for HAND 
participants confirm and build on prior work that examined cortical atrophy in 
HIV+ participants. Aylward and colleagues (1995) reported their HIV+ group with 
dementia as having a significantly smaller posterior gray matter percentage than 
non-demented HIV+ and HIV- control participants. No group differences were 
found for measurements of anterior gray matter in that study. Wiley and 
colleagues (1991) reported atrophy of the cortical ribbon that was most evident in 
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the parietal and temporal regions of neocortex in patients with HIV encephalitis. 
Finally, in a study carried out by Elovaara and colleagues (1990) using qualitative 
neuroradiological evaluation, the most pronounced degeneration of HIV+ 
participants who exhibited cortical atrophy was found in the temporal lobes. More 
recent imaging studies have reported cortical thinning in anterior cingulate and 
temporal cortices (Küper et al., 2011), primary sensory and motor cortices, 
parietal association cortex, medial frontal and premotor cortex (Thompson et al., 
2005), posterior and inferior temporal lobes, parietal lobes, and cerebellum 
(Becker et al., 2012). While we did not hypothesize that regional thickness in the 
occipital lobe would be increased in the CAHIV+ individuals when compared to 
control participants, elevated volume estimates for subcortical gray matter 
(Jernigan et al., 2011) and putamen volumes (Castelo et al., 2007) have been 
previously reported for the HIV+ population.  
The characteristic neuropsychological symptomatology in HIV+ 
participants includes working memory dysfunction, lack of mental flexibility 
(Sahakian et al., 1995), decreases in motor and psychomotor speed ((Llorente et 
al., 1998; Villa et al., 1996), and  increases in simple reaction time (Karlsen et al., 
1992; Law et al., 1995; Mellgren et al., 2000) and reaction time during response 
inhibition (Hinkin et al., 1999; Llorente et al., 1998). Taking into account these 
findings, which are suggestive of fronto-striatal dysfunction in participants during 
varying stages of HIV illness, it was surprising to find no significant evidence of 
reduced thickness in the prefrontal cortex for our participants. One possibility is 
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that the cognitive deficits attributed to changes in the fronto-striatal system are 
due to white matter damage that spares prefrontal cortical regions. A recent DTI 
investigation found increased mean diffusivity (MD) in the white matter of the 
posterior frontal lobe for neurologically asymptomatic HIV+ patients when 
compared to a control group (Zhu et al., 2013). 
Our demonstration of reduced cortical thickness measures in the STG in 
patients free from HAND is interesting given the hypothesized functions of this 
region. With primary auditory cortex housed within the STG and abutting 
Wernike’s area, it is unsurprising that intracranial electroencephalography (iEEG) 
investigations have linked the STG to speech perception (Chan et al., 2014; E. F. 
Chang et al., 2010).  A recent magnetoencephalography (MEG) study revealed 
the necessity of the STG in attending to speech in a “multitalker” situation with 
noise distractors (Vander Ghinst et al., 2016). A number of studies have 
documented hearing difficulties in HIV+ individuals (Zuniga, 1999). One such 
report stated that HIV+ individuals on a steady regimen of antiretroviral therapy 
(ART) had significantly greater difficulties understanding speech in noise, and 
were significantly more likely to report that they had difficulty 
understanding speech than the patients not taking medication (Maro et al., 2014). 
This finding is line with the hypothesis that antiretroviral medications have an 
ototoxic effect (Thein, Kalinec, Park, & Kalinec, 2014). 
Additional research has suggested that the STG is damaged in patients 
with spatial neglect (Karnath, Rennig, Johannsen, & Rorden, 2011; Kenzie et al., 
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2015; Rousseaux, Allart, Bernati, & Saj, 2015), and that it is necessary for spatial 
processing (Mayer, Dorflinger, Rao, & Seidenberg, 2004), and feature-based 
serial exploratory search tasks (Ellison, Schindler, Pattison, & Milner, 2004; 
Gharabaghi, Fruhmann Berger, Tatagiba, & Karnath, 2006). HIV+ patients have 
deficits in related spatial and attentional tasks. For example, one study reported 
that HIV+ participants perform significantly worse than control participants on a 
spatial variant of the N-back working memory task (Hinkin et al., 2002) while 
another found HIV-related deficiencies on a visuospatial temporal ordering task 
(Woods et al., 2013). Results of a study assessing automobile driving 
performance in a group of HIV+ patients as compared to control participants 
showed that the HIV+ participants who were also neuropsychologically impaired 
performed poorly on a spatial navigation task that required mental rotation 
(Marcotte et al., 2004).   
A potential explanation for the smaller thickness measurement of the STG 
in CAHIV+ individuals when compared to the HIV- control group comes from 
anatomical research showing that the STG has direct connections with the 
caudate nucleus and putamen in monkeys (Yeterian & Pandya, 1998). 
Specifically, the rostral and middle parts of the STG project to ventral portions of 
the head, body, and tail of the caudate nucleus while the caudal STG project to 
the dorsal head and body of the caudate. The rostral and middle STG are 
connected to the rostroventral and caudoventral putamen and the caudal STG 
projects to the caudodorsal putamen (Yeterian & Pandya, 1998). There is a 
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wealth of evidence supporting basal ganglia dysfunction associated with HIV 
infection (for review see Berger and Arendt, 2000). The results presented here 
suggest that HIV infection damage may include the STG in addition to the basal 
ganglia.  
The other statistically significant difference found in the CAHIV+ group 
was increased thickness of the inferior occipital gyrus (IOG) as compared to the 
HIV- control group. While we hypothesized that reduced cortical measures would 
be observed for the CAHIV+, other studies have reported putamen hypertrophy 
(Castelo et al. 2007) and brain volume increases in the HIV+ population 
(Jernigan et al., 2011) where immune activation was thought to lead to mild 
swelling of tissues. A similar hypothesis has been made regarding increases in 
cortical volumes associated with substance dependence (Jacobsen, Giedd, 
Gottschalk, Kosten, & Krystal, 2001; Jernigan et al., 2005). Another possible 
explanation is that underlying white matter damage would be expected to result 
in increased thickness of the cerebral cortex in HIV.  
Located within the IOG is an area that has been dubbed the occipital face 
area or OFA (Gauthier et al., 2000). A variety of imaging studies have associated 
OFA activation with accurate face perception, suggesting that it constructs an 
initial representation of a face (see Pitcher et al., 2011 for a review). Impairment 
on a facial emotion recognition task has been associated with reduced 
subcortical volumes in HIV+ individuals (Clark et al., 2015). Disruption in this 
area may account for some of the other visuospatial (Bogdanova et al., 2008; 
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Hinkin et al., 2002; Marcotte et al., 2004; Olesen et al., 2007) and attentional 
(Chang et al., 2004) difficulties documented in the HIV population. 
We have demonstrated both reduced thickness measures of the cerebral 
cortex within the temporal lobe and increased thickness measures of the occipital 
cortices in HIV+ patients without HAND using an automated computational 
approach that estimated thickness across the entire cortical mantle from high-
resolution MR images (Fischl & Dale, 2000). Although these methods utilized 
high quality data sets and have been validated using histological methods 
(Rosas et al., 2002) as well as manual methods (Kuperberg et al., 2003; Salat et 
al., 2004), it is possible that increases in white matter signal intensities 
associated with HIV infection could alter the placement of the gray matter/white 
matter boundary (Thurnher et al., 2000). Motion correcting, averaging of two 
scans per participant, and visual inspection of each surface for accuracy reduces 
this potential confound. Additionally, having similar findings in both the 
preliminary group of 20 participants and an independent sample of 39 
participants suggests that our results are reliable. However, it is also important to 
consider further the variability within the participant group itself. While all HIV+ 
participants were well characterized in terms of neuropsychological assessment 
according to the guidelines recommended by the National Institutes of Health 
(Antinori et al., 2007), they were fairly diverse in terms of CD4 counts, plasma 
viral loads, years since diagnosis, and medication status. We compared 
thickness in the STG and inferior occipital gyrus across CAHIV+ groups based on 
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the type of medicinal regimen they are on given that other reports have 
postulated that taking HAART may have an influence on gray matter volume in 
HIV+ individuals (Corrêa et al., 2016; Kallianpur et al., 2012).There was no 
difference among groups, suggesting that medication does not contribute to the 
observed effects (Figures 3.3). The results of this study suggest that selective 
alteration of the cerebral cortex begins during the cognitively asymptomatic 
stages of HIV-infection within the temporal and occipital cortices. 
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Table 3.1. Subject demographics for cognitively asymptomatic HIV-positive 
participants (CAHIV+) and HIV- control participants (HIV-) presented as means 
with standard deviations. P-values reflect results of independent sample t-tests. 
NART: National Adult Reading Test. 
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 HIV- CAHIV+ p-
values 
N 19 22 N/A 
Age 41.3 ± 9.64  
(26-61) 
41.14 ± 9.23  
(22-59) 
0.94 
    
Education (years) 16.1 ± 1.96  
(12-19) 
15.4 ± 1.81  
(12-18) 
0.14 
    
NART Estimated 
Verbal IQ 
119.7 ± 4.04  
(107.3-124.3) 
115.1 ± 9.93  
(86.9–125.1) 
0.07 
    
Handedness 89% Right 86% Right 0.77 
†CD4 count at 
testing 
N/A 649.7 ± 344.2  
(249-1433) 
N/A 
    
†Viral load at testing 
(copies/µl) 
N/A 6.8 ± 11.4  
(Undetectable – 43.8) 
N/A 
    
†Years since HIV+ 
diagnosis 
N/A 8.7 ± 5.3 
(1-20) 
N/A 
    
Antiretroviral 
medications 
N/A 10 HAART 
2 non-HAART 
N/A 
  10 None  
HIV Dementia 
Screening Score 
N/A 15.3 ± 1.2 (12-16) N/A 	  
† Information not available for two CAHIV+ participants. 
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Table 3.2. Subject demographics for a subset of the cognitively asymptomatic 
HIV-positive participants (CAHIV+) as compared to patients with HIV-associated 
neurocognitive disorder (HAND) presented as means with standard deviations. 
P-values reflect results of independent sample t-tests. NART: National Adult 
Reading Test. 
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 HAND CAHIV+ p-
values 
N 7 8 N/A 
Age 40.3 ± 7.83  
(31-51) 
43.13 ± 10.9  
(22-54) 
0.58 
    
Education (years) 13 ± 1.53  
(12-16) 
14.5 ± 1.69  
(12-16) 
0.10 
    
NART Estimated 
Verbal IQ 
103.0 ± 7.07  
(94.0-108.2) 
107.8 ± 11.0  
(86.9–118.9) 
0.34 
    
Handedness 100% Right 87.5% Right 0.37 
†CD4 count at 
testing 
556 ± 324.1 
(492-878) 
689.5 ± 406.7  
(267-1240) 
0.60 
    
¢Viral load at 
testing (copies/µl) 
3.73 ± 5.3 
(0.075-7.4) 
9.8 ± 17.1  
(0.05 – 43.8) 
0.66 
    
§Years of 
diagnosis 
14 (10-20) 
 
9.2 ± 5.4 (3-20) 0.32 
§Antiretroviral 
medications 
3 HAART 
1 non-HAART 
3 None 
 
3 HAART 
1 non-HAART 
4 None 
 
HIV Dementia 
Screening Score 
14.1 ± 1.9 
(11-16) 
14.3 ± 1.5  
(12-16) 
0.85 	  
† Information not available for 3 HAND and 2 CAHIV+ participants. 
¢ Information not available for 5 HAND and 2 CAHIV+ participants. 
§ Information not available for 4 HAND one 1 CAHIV+ participant. 
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Table 3.3. Regions of interest thickness measures (in mm) presented as mean, 
standard error of the mean, and range for CAHIV+ as compared to HIV- 
participants (A) and HAND patients as compared to a subset of the CAHIV+ 
group. 
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A. 
Region Name ROI # 
from 
Fig. 3.2 
HIV- Mean ± 
SE 
(range) 
CAHIV+ Mean ± 
SE 
(range) 
p-value 
Left Superior 
Temporal Gyrus 
(Planum Polare) 
35 3.28 ± 0.80 
(2.95-3.79) 
3.08 ± 0.78 
(2.66-3.57) 
 
0.014 
Right Inferior 
Occipital Gyrus 
2 1.57 ± 0.38 
(1.24-2.23) 
 
1.89 ± 0.51 
(1.33-2.41) 
0.001 
 
B. 
Region Name ROI # 
from 
Fig. 3.2 
CAHIV+ 
Mean ± SE 
(range) 
HAND Mean ± 
SE 
(range) 
p-value 
Left Superior 
Temporal Gyrus 
(Transverse) 
74 2.06 ± 0.43 
(1.88-2.22) 
1.96 ± 0.43 
(1.91-2.01) 
 
0.054 
Right Cingulate 
Sulcus 
7 2.36 ± 0.60 
(2.31-2.44) 
 
2.21 ± 0.58 
(2.08-2.46) 
0.013 
Left Intraparietal 
Sulcus  
56 1.73 ± 0.38 
(1.50-2.0) 
1.54 ± 0.34 
(1.42-1.66) 
 
0.020 
Right Intraparietal 
Sulcus 
56 1.71 ± 0.36 
(1.47-1.91) 
 
1.51± 0.39 
(1.41-1.59) 
0.003 
Right Postcentral 
Sulcus 
67 1.65 ± 0.44 
(1.49-1.79) 
 
1.51 ± 0.41 
(1.41-1.79) 
0.020 
Left Angular Gyrus 25 2.33 ± 0.12 
(2.19-1.54) 
 
2.15 ± 0.13 
(1.91-2.2) 
0.024 
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Figure 3.1. The preliminary average statistical map of 30 participants with HIV 
(including CAHIV+, HAND, and unclassified patients) as compared with the 
average map of 29 HIV- participants. Maps are presented on the semi-inflated 
cortical surface of an average brain with darker gray areas corresponding to sulci 
and lighter gray areas corresponding to gyri. Non-neocortical regions and regions 
that are not part of the cortical mantle (i.e. the corpus callosum) have been 
excluded from the analysis. The colorscale represents the significance of the 
thickness change with yellow indicating regions with the greatest between group 
reduction in thickness measures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  82 
Figure 3.2. Anatomical parcellations corresponding to the numbered regions of 
interest (ROIs) reported in Table 3.3 as previously published (Destrieux et al., 
2010). These were created using an automated parcellation technique based on 
a manually labeled training set using cortical folds for regional boundaries (Bruce 
Fischl et al., 2004).  
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Figure 3.3. The average superior temporal gyrus (STG) and inferior occipital 
gyrus (IOG) thickness (in mm) for 19 HIV- control participants, 22 CAHIV+ 
participants sorted into a group taking HAART (n=11), and a CAHIV+ group not 
on a HAART regimen (n=11). This graph demonstrates that there is not a strong 
effect of medication on STG or IOG thickness in the CAHIV+ group. 
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CHAPTER FOUR 
 
Experiment 3: Regional white and gray matter alterations are related  
to performance measures of HIV-associated neurocognitive disorder 
 
INTRODUCTION 
Previous studies have demonstrated an association between WM volume 
loss and cognitive decline in HIV (Aylward et al., 1993; Stout et al., 1998).  
Investigations using MR imaging to focus on WM tracts have shown that whole-
brain DTI measurements correlate with cognitive deficits in HIV positive patients 
(Ragin et al., 2004; Tate et al., 2010). Specifically, regional DTI measurements 
acquired in the corpus callosum (Hoare et al., 2012; Nir et al., 2014; Schulte et 
al., 2008; V. M. Tang et al., 2015; Wu et al., 2006; Zhu et al., 2013), corona 
radiate (Hoare et al., 2012; Nir et al., 2014; Zhu et al., 2013), uncinate fasciculus 
(Schulte, Muller-Oehring, Sullivan, & Pfefferbaum, 2012), frontal WM (Chang et 
al., 2008; Wu et al., 2006), parietal WM (Chang et al., 2008), sagittal stratum 
(Hoare et al., 2011), subcortical structures (Chang et al., 2008; Ragin et al., 
2005), anterior commissure, and internal capsule (V. M. Tang et al., 2015) 
correlate with a host of different cognitive deficits in HIV positive patients. 
Additionally, DTI fiber-tracking measures in the splenium (Pfefferbaum et al., 
2007) and cerebellum (Sullivan et al., 2011) have predicted slowed psychomotor 
performance in HIV-infected groups. 
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Cortical atrophy in HIV+ participants has been associated with slowed 
information processing (Harrison et al., 1998) and poor memory test performance 
(Harrison et al., 1998; Poutiainen et al., 1993) as well. While poorer performance 
on neuropsychological measures has correlated with reduced regional brain 
volumes in HIV+ individuals (Becker et al., 2012; Castelo et al., 2007; Corrêa et 
al., 2016; Küper et al., 2011; Paul et al., 2008; Thompson et al., 2005) in more 
recent imaging studies as well. Other disease-related factors of HIV-illness have 
been associated with cortical degeneration as well. HIV+ patients who had 
experienced an AIDS-defining event have shown thinner primary sensory, motor, 
and premotor cortices (Thompson et al., 2005), smaller cortical volumes with 
larger ventricles (Cohen et al., 2010), and smaller volumes in the corpus 
callosum (Pfefferbaum et al., 2006; Thompson et al., 2006). Brain volume 
abnormalities have been associated with the lowest CD4 lymphocyte count 
measured after HIV infection, referred to as the nadir CD count, (Clark et al., 
2015; Jernigan et al., 2011; Pfefferbaum et al., 2012) and plasma viral load as 
well (Cardenas et al., 2009; Jernigan et al., 2011).  
Other studies have investigated the association between HIV-associated 
structural changes and a series of cognitive domains recommended for HAND 
classification by The National Institute of Mental Health and The National Institute 
of Neurological Diseases and Stroke (Antinori et al., 2007). One report looked at 
the changes in a global cognitive deficit score, where all individual domains were 
averaged, one year after baseline measurements were recorded for in HIV+ 
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participants. They found that overall cognitive deficits correlated with FA 
alterations in parietal and frontal WM and putamen (Chang et al., 2008). Another 
investigation utilized tract-based special statistics (TBSS) to calculate DTI 
measures throughout all white matter tracts for HIV-infected participants with and 
without cognitive impairment as compared to healthy control participants (Zhu et 
al., 2013). The study found that two cognitive domains – speed of information 
processing and verbal fluency – significantly correlated with reduced FA and 
increased mean diffusivity values across multiple WM structures. However, to our 
knowledge, no prior work has investigated the relationship between cortical and 
WM regions previously associated with HIV-infection and cognitive domains 
known to be sensitive to the detection of HIV-associated neurocognitive 
disorders (HAND). 
Thus, the purpose of the present study was to identify correlations 
between cortical volumes, DTI FA values, neuropsychological test performance, 
and immunological characteristics of HIV-infection.  Using stepwise multivariate 
linear regressions, we sought to identify whether cortical thickness, WM integrity, 
and immunological markers of HIV-infection correlate with neuropsychological 
performance. We hypothesized that regional FA values, cortical thickness, and 
viral load would be related to neuropsychological composite scores for CAHIV+ 
individuals, but not HIV- control participants. 
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METHODS 
Participants.  
Twenty-eight HIV-negative (HIV-) participants and 30 HIV-positive 
participants were analyzed in this study.  For the HIV+ participants, 23 were 
cognitively asymptomatic (CAHIV+), and 7 participants were cognitively 
symptomatic using the criteria for HIV-associated neurocognitive disorders 
(HAND). All participants were recruited for Experiments 1 and 2, following the 
same exclusionary criteria, neuropsychological assessment, and immunological 
data collection outlined in those Methods sections of chapters 2 and 3.  
 
Correlational Analyses. 
Five structural ROIs were examined for correlation with 
neuropsychological test performance: frontotemporal WM, posterior corpus 
callosum WM, parietal WM, STG thickness, and IOG thickness. Bivariate 
correlation analyses were only implemented to examine relationships for regions 
with FA and cortical thickness differences between the cognitively asymptomatic 
HIV+ and HIV- groups as reported in Experiments 1 and 2. The relationship 
between FA values, cortical thickness, and immunological health characteristics 
(CD4 counts and plasma viral loads) was explored for both the cognitively 
asymptomatic HIV+ and HAND groups. A set of secondary post-hoc analyses 
were carried out in which we combined the asymptomatic HIV+ and HAND 
groups to explore correlations between FA values and cognitive performance for 
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our entire HIV positive population. Statistical analyses were performed using 
SPSS, version 23.0 statistical analysis software for Macintosh (SPSS Inc, 
Chicago, Illinois).  
 
Regression Analyses. 
Stepwise multivariate linear regressions were implemented to examine the 
extent to which structural alterations in the WM and cortex, identified in 
Experiments 1 and 2, affected neuropsychological performance. Six cognitive 
composite scores (attention/working memory, abstraction/executive function, 
speed of information processing, memory (learning and recall), motor speed, and 
verbal fluency and language) were computed in the following manner. First, all 
raw scores were computed to z scores based on published normative data. 
The z scores for the tests in a given cognitive category were then averaged to 
compute 1 composite score per person for each cognitive domain. Finally, the z 
scores from each cognitive domain were averaged to create a single global 
functioning score. The global functioning composite score was entered as the 
dependent variable while CD4 lymphocyte count, viral load, duration of illness, 
and each of the ROIs, and were submitted as independent variables in the 
stepwise linear regression model. Statistical analyses were performed using 
SPSS, version 23.0 statistical analysis software for Macintosh (SPSS Inc, 
Chicago, Illinois). 
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RESULTS 
WM FA and Neuropsychological/Immunological Characteristic Correlations. 
The association between FA and neuropsychological test performance 
was calculated separately for each participant group. The relationship with 
cognitive performance was only explored for regions showing between-group 
differences in FA measures collected in Experiment 1 (frontotemporal, posterior 
corpus callosum, parietal lobe). HIV negative subjects had no significant 
associations with cognitive domain scores. For the cognitively asymptomatic 
HIV+ group, the negative correlation between viral load and right parietal FA was 
significant (r=-.660, p=.010) where viral load increases with lower FA values. The 
cognitively asymptomatic group also had a significant negative correlation 
between left posterior corpus callosum FA and one measure of the verbal 
fluency/language abilities domain (Boston Naming Test score, r=-.518, p=.040) 
such that lower FA is correlated with better test performance.  The HAND group 
showed a negative correlation between frontotemporal FA and the Attention/ 
Working Memory cognitive domain (r=-.950, p=.004) so that FA increases as 
performance decreases. In the combined HIV positive group (asymptomatic HIV+ 
and HAND), correlations were identified where FA increased as test performance 
decreased. These include left posterior callosum FA and the Attention/Working 
Memory Domain (r=-.446, p=.038), and the Verbal Fluency Domain (r=-.478, 
p=.029). Increased viral load correlated with increased FA in the left posterior 
callosum as well (r=.506, p=.032). These results are outlined in Table 4.1A. 
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Cortical Thickness and Neuropsychological/Immunological Characteristic 
Correlations. 
The association between cortical thickness and neuropsychological test 
performance was calculated separately for each participant group. Relationship 
with cognitive performance was only explored for regions showing between-
group differences in cortical thickness measures in Experiment 2 (superior 
temporal gyrus, inferior occipital gyrus, cingulate sulcus, intraparietal sulcus, 
postcentral sulcus and angular gyrus) as shown in Table 3.3. For participants 
with HAND, correlations were identified between the Attention/Working Memory 
domain score and the right superior temporal sulcus (r=.906, p=.013) and right 
cingulate gyrus (r=.902, p=.014), the Abstraction/Executive Function domain 
score and the right intraparietal sulcus (r=.818, p=.047), and the global 
functioning score and right superior temporal sulcus (r=.906, p=.005) where 
cortical thickness decreases as test performance decreases.  
While the CAHIV+ participants had no significant associations with 
cognitive domain scores on their own, a number of additional correlations were 
significant once the HIV+ groups (CAHIV+ and HAND) were combined. These 
included the Attention/Working Memory domain score with the transverse aspect 
of the left STG (r=.419, p=.03) and the right superior temporal sulcus (r=.486, 
p=.01), the Memory (Learning and Recall) domain score with the right superior 
temporal sulcus (r=.386, p=.042), the right intraparietal sulcus (r=.458, p=.014), 
and the right postcentral sulcus (r=.483, p=.009), the Verbal Fluency/ Language 
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domain score with the left temporal pole (r=.428, p=.037), and the global 
functioning score with the right intraparietal sulcus (r=.374, p =0.046) and the 
right postcentral sulcus (r=.492, p=.007). All associations were such that 
thickness decreased as test performance decreased. An additional significant 
correlation included viral load with the Verbal Fluency/ Language Domain, (r=.-
636, p=.003) where viral load increased as test performance decreased. For the 
HIV- group, a correlation between thickness in the planum polare of the STG and 
the Memory (Learning and Recall) domain score was significant (r=.561, p=.003) 
where STG thickness decreases with lower test score. These results are outlined 
in Table 4.1A. 
 
WM FA and Cortical Thickness Correlations. 
The association between white matter fractional anisotropy and cortical 
thickness was calculated separately for each participant group. The CAHIV+ 
individuals demonstrated significant correlations between angular gyrus 
thickness and both frontotemporal (r=.623, p=0.017) and right posterior callosum 
(r=.566, p=0.035) where FA increases along with angular gyrus thickness. Those 
same relationships between angular gyrus thickness and frontotemporal (r=.529, 
p=0.017) and right posterior callosum (r=.659, p=0.002) FA were significant for 
the combined HIV+ group (CAHIV+ and HAND together) as well. The HAND 
individuals also had a significant association between the angular gyrus and right 
posterior callosum FA (r=.942, p=.017) (Figures 4.1 and 4.2). Temporal pole 
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thickness decreases correlated with left posterior callosum FA increases in both 
CAHIV+ (r=-.602, p=.008) and all HIV+ (r=-.430, p=.032) (Figure 4.3). HAND 
participants showed an additional correlation between frontotemporal FA and 
superior temporal sulcus thickness (r=-.869, p=0.025) where frontotemporal FA 
increases as superior temporal sulcus thickness decreases. The combined HIV+ 
group additionally had a significant association between frontotemporal FA and 
the cingulate gyrus (r=-.445, p=0.026 ), where frontotemporal FA increases as 
cingulate gyrus thickness decreases. For HIV- participants, the only significant 
correlation identified was between right inferior occipital gyrus thickness and 
parietal FA (r=.602, p=0.014). These results are outlined in Table 4.1B. 
 
Regression Analyses.  
To assess the extent to which immunological health, FA alterations, and 
cortical thickness affected cognitive function in the HIV+ groups, a stepwise 
linear regression analysis was conducted. In the model, immunological health 
characteristics (CD4 lymphocyte count, plasma viral load, duration of illness), the 
significant ROIs for CAHIV+ individuals from Experiment 1 (frontotemporal FA, 
posterior callosum FA, parietal lobe FA), and Experiment 2 (superior temporal 
gyrus and inferior occipital gyrus thickness) were submitted as independent 
variables, and the global functioning composite score was the dependent 
variable. The model was not statically significant for the CAHIV+, HAND, or 
combined HIV+ group.  
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DISCUSSION 
A series of statistical analyses were calculated to further investigate the 
relationship between altered FA and cortical thickness measures identified in the 
CAHIV+ group in Experiments 1 and 2, neuropsychological scores, and 
immunological markers of HIV disease,. The most significant ROIs identified for 
CAHIV+ individuals included the increased frontotemporal FA (p=.00008) in 
Experiment 1 and the decreased superior temporal gyrus thickness (p=.01) and 
the increased inferior occipital gyrus thickness (p=.001) in Experiment 2. While 
there were no significant correlations identified between frontotemporal FA and 
cognitive measures for the HIV- or cognitively asymptomatic HIV+ group, the 
HAND cohort showed a correlation in this region where frontotemporal FA 
increased as performance on the Attention/Working Memory cognitive domain 
decreased. These data suggest that FA alterations identified in the absence of 
cognitive impairment contribute to the cognitive deficits seen in more advanced 
stages of HIV disease. When the cognitively asymptomatic HIV+ and HAND 
groups were combined, this association was no longer significant. While the 
small sample size limits the conclusions we can draw, it is possible that there is a 
nonlinear association between FA in frontotemporal regions and cognition in HIV 
such that cognitive deficits arise after significant damage to the underlying white 
matter occurs. This would support previous findings where a significant 
association between neurocognitive domains (Speed of Information Processing 
and Verbal Fluency) and altered diffusion measures across multiple WM 
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structures in HIV+ individuals were demonstrated (Zhu et al., 2013). 
While the CAHIV+ participants had no significant associations between 
cognitive domain scores and superior temporal gyrus or inferior occipital 
thickness on their own, a number of correlations involving the superior temporal 
region were significant once the HIV+ groups (CAHIV+ and HAND) were 
combined. These included the Attention/Working Memory domain score with the 
transverse aspect of the left STG and the right superior temporal sulcus, and the 
Memory (Learning and Recall) domain score with the right superior temporal 
sulcus. These results are similar to the cognitive associations we identified for 
frontotemporal FA in the HAND cohort; the results further suggest that the 
cortical alterations documented in the absence of cognitive impairment may 
contribute to the cognitive deficits seen as HAND progresses. It is also important 
to note that no significant interactions were identified between 
neuropsychological performance and these regions for the HIV- group.  
Several anatomical relationships were identified for the HIV+ groups that 
were not evident in the HIV- participants. Namely, FA in the right posterior corpus 
callosum correlated with angular gyrus thickness in the CAHIV+, HAND, and 
combined HIV+ groups. Angular gyrus thickness also correlated positively with 
frontotemporal FA for the CAHIV+ and combined HIV+ groups. These results 
were somewhat unexpected given the direction of the association. Both posterior 
callosum and frontotemporal FA increased in the HIV+ groups when compared to 
HIV- measurements (as detailed in chapter 2), but angular gyrus thickness 
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decreased in the HAND group when compared to the subset of CAHIV+ 
individuals. As discussed in chapter 3, increased volumetric measures have been 
documented in the HIV+ population before, potentially due to edema of the 
neural tissue (Jernigan et al., 2011). These correlations suggest increased 
angular gyrus volumes for the HIV+ groups. This finding is interesting given fMRI 
evidence for HIV-associated hyperactivity in the posterior parietal lobe during 
both an episodic encoding task (Castelo, Sherman, Courtney, Melrose, & Stern, 
2006) and mental rotation task (Schweinsburg et al., 2012). The other significant 
anatomical finding for both CAHIV+ and the combined HIV+ group was an 
inverse correlation between left posterior corpus callsoum FA and the temporal 
pole. This finding is in agreement with the posterial callosum FA increase 
reported in the chapter 2 and the temporal pole decrease reported in chapter 3. 
There were no significant correlations identified for the HIV- individuals involving 
the increased FA measures in the frontotemporal or posterior corpus callosum 
regions. This is further evidence to suggest that these associations within the 
temporal lobe are unique for HIV+ participants, even those free from HAND.  
Fewer associations between immunological characteristics and either 
structural ROIs or cognitive performance were identified than hypothesized. No 
signification correlations were found for CD4 lymphocyte count or years since 
diagnosis. This is likely due to the fact that we collected CD4 count from our 
patients at the time the neuropsychological battery was administered. However, 
nadir CD4 count has been shown to be a superior predictor of HIV-associated 
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cognitive impairment (Ellis et al., 2011). We found that viral load increased as 
test performance on the Verbal Fluency/Language Domain decreased, but we 
also observed a negative relationship between viral load and right parietal FA for 
CAHIV+, which is not entirely consistent with the between group finding in 
Experiment 1. As viral load increases, it would be expected that FA values drop.  
While our regressional analyses failed to show that altered FA and cortical 
measures are able to predict global neuropsychological functioning, several 
unique correlations were identified for the HIV+ groups when compared to the 
HIV- control participants. The results of this study highlight a pattern of 
association between neuropsychological test performance and regional 
alterations found in the cortex and white matter for HIV+ individuals. This is most 
pronounced in the temporal lobe, suggesting that regional changes to WM and 
cortex that occur while HIV patients are cognitively asymptomatic may contribute 
to the deficits seen as HAND develops.  
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Table 4.1. A. Correlations between structural ROIs (calculated in Experiments 1 
and 2) and cognitive domain scores. B. Correlations between regional FA values 
(calculated in Experiment 1) and cortical thickness measures (calculated in 
Experiment 2). PCC = posterior corpus callosum, STG = superior temporal gyrus,  
STS = superior temporal sulcus, AWM = Attention/Working Memory, VF = Verbal  
Fluency/Language, MLR = Memory (Learning and Recall), AEF =  
Attention/Executive Function, GF = Global Functioning. 
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A. 
GROUP ROI Cognitive 
Domain 
Pearson’s 
r 
p-value 
All HIV+ Left PCC FA AWM -.446 0.038 
All HIV+ Left PCC FA VFL  -.478 0.029 
All HIV+ STG, Transverse AWM  .419 0.03 
All HIV+ Right STS AWM  .486 0.01 
All HIV+ Right STS MLR  .386 0.042 
All HIV+ Right Intraparietal Sulcus MLR  .458 0.014 
All HIV+ Right Intraparietal Sulcus GF  .374 0.046 
All HIV+ Right Postcentral Sulcus MLR  .483 0.009 
All HIV+ Right Postcentral Sulcus GF .492 0.007 
All HIV+ Left Temporal Pole VFL  .428 0.037 
HAND Frontotemporal FA AWM  -.950 0.004 
HAND Right STS AWM  .906 0.013 
HAND Right STS GF .906 0.005 
HAND Right Cingulate Gyrus AWM  .902 0.014 
HAND Right Intrapatietal Sulcus AEF  .818 0.047 
HIV- STG, Planum Polare MLR  .561 0.003 
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B. 
GROUP WM ROI Cortical 
Thickness ROI 
Pearson’s 
r 
p-
value 
CAHIV+ Frontotemporal FA Angular Gyrus .623 0.017 
CAHIV+ Left PCC FA Temporal Pole -.602 0.008 
CAHIV+ Right PCC FA Angular Gyrus .566 0.035 
All HIV+ Left PCC FA Temporal Pole -.430 0.032 
All HIV+ Frontotemporal FA Cingulate Gyrus -.445 0.026 
All HIV+ Right PCC FA Angular Gyrus .659 0.002 
All HIV+ Frontotemporal FA Angular Gyrus .529 0.017 
HAND Frontotemporal FA STS -.869 0.025 
HAND Right PCC FA Angular Gyrus .942 0.017 
HIV- Left Parietal FA Right IOG .602 0.014 
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Figure 4.1. Elevated FA measures in frontotemporal white matter for both 
CAHIV+ and all HIV+ patients are associated with increases in angular gyrus 
thickness.  
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Figure 4.2. Elevated FA measures in posterior corpus callosum white matter for 
CAHIV+, HAND, and all HIV+ patients are associated with increases in angular 
gyrus thickness.  
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Figure 4.3. Elevated FA measures in posterior corpus callosum white matter for 
CAHIV+ and combined the combined HIV+ patient groups are associated with 
decreases in temporal pole thickness.  
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CHAPTER FIVE 
 
Integrated Discussion 
 
The goal of this thesis was to examine the associations between HIV-
related structural brain changes in the white matter and cortex, 
neuropsychological performance on tests sensitive to HAND identification, and 
immunological characteristics in a group of cognitively asymptomatic HIV+ 
(CAHIV+) patients without HAND as compared to well-matched control 
participants (HIV-). The integration of diffusion tensor imaging (DTI), structural 
magnetic resonance imaging (sMRI), and neuropsychological testing allowed for 
a comprehensive investigation of these structure-function relationships in the pre-
dementia stages of HIV illness. DTI was used to collect regional fractional 
anisotropy (FA) values reflective of white matter integrity in both cognitively 
asymptomatic HIV+ individuals (CAHIV+) and well-matched control participants. 
Additionally, sMRI was used to collect regional cortical thickness measurements 
in both of these groups. Neuropsychological measures were utilized in all three 
studies for the purpose of staging HIV+ participants regarding HAND severity so 
that only HIV+ participants free from any form of neurocognitive disorder 
(asymptomatic, mild, or dementia) were included in the CAHIV+ groups. The 
neuropsychological measures were also used to examine the relationship 
between structural measures and cognition. This discussion section will briefly 
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summarize the main findings of each experiment and offer integrative 
interpretations for the collective results. 
 
SUMMARY OF FINDINGS 
 Results from Experiment #1 (chapter 2) documented significantly elevated 
FA values in frontotemporal white matter (WM) in cognitively asymptomatic HIV+ 
(CAHIV+) individuals, compared to well- matched control participants. Based on 
earlier studies, the prediction  was that WM changes would be evident in the 
CAHIV+ group and be most prominent in the corpus callosum with alterations in 
the internal capsule, frontotemporal, and parietal, WM. While a subset of studies 
have reported increased FA values in various WM regions for the HIV+ 
population, the majority report reduced FA, particularly in the corpus callosum. 
Along with the increased FA in the frontotemporal region, we found increased FA 
in the posterior callosum for CAHIV+ individuals, and reduced FA in the parietal 
ROI.  
 Results from Experiment #2 (chapter 3) revealed statistically significant 
reduced cortical thickness measures in the superior temporal gyrus (STG) for the 
CAHIV+ group as compared to the HIV- control participants. A 17% increase in 
thickness was calculated in the inferior occipital gyrus (IOG) for CAHIV+ 
individuals as well. While our prediction was that CAHIV+ participants would 
show signs of reduced cortical thickness across frontal, temporal, and parietal 
when compared to HIV- control individuals, significant cortical alterations were 
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confined to the STG and IOG for the patients free from HIV-associated 
neurocognitive disorder (HAND). 
Finally, the results from Experiment #3 (chapter 4) highlighted significant 
relationships between the same ROIs calculated in Experiment #1 and #2 
(chapters 2 and 3, respectively) and measures of neuropsychological 
performance and immunological health. For CAHIV+ individuals, associations 
were revealed between both frontotemporal and posterior callosum FA with 
thickness of the angular gyrus and posterior callosum FA with temporal pole 
thickness. These relationships were not significant for the HIV- individuals. While 
none of the cognitive domain scores (calculated from neuropsychological tests 
known to be sensitive to HAND) correlated significantly with the structural ROIs 
for CAHIV+ participants, there was a relationship between increased FA in the 
posterior callosum and poorer performance the Boston Naming Test - one 
measure of the Verbal Fluency/Language abilities domain. CAHIV+ individuals 
also had a significant relationship between viral load and right parietal FA where 
viral load increased with lower FA values. When the CAHIV+ and HAND groups 
were combined, a number of significant correlations between structural ROIs and 
cognitive domain scores were identified. These findings suggest that regional 
changes to WM and cortex that occur while HIV patients are cognitively 
asymptomatic may contribute to the deficits seen in the later stages of HIV illness 
as HAND develops.  
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PRE-HAND STRUCTURAL BRAIN CHANGES  
The findings from Experiments #1 and #2 are consistent with previous 
imaging studies of HIV+ patients where regional WM injury has been 
documented in the corpus callosum ( Hoare et al., 2011, 2012; Leite et al., 2013; 
X. J. Li et al., 2015; Müller-Oehring et al., 2010; Nir et al., 2014), frontal (J. Li et 
al., 2015; Pomara et al., 2001; Smith et al., 2008; Stebbins et al., 2007; Thurnher 
et al., 2005; Zhu et al., 2013), temporal (Gongvatana et al., 2011), and parietal 
(Chang et al., 2008; Gongvatana et al., 2011; J. Li et al., 2015; Stebbins et al., 
2007) lobes and regional cortical thinning has been reported in the temporal 
cortices (Becker et al., 2012; Küper et al., 2011) various stages of illness. 
However, in Experiments #1 and #2, the HIV+ patients in the CAHIV+ group 
were limited to those showing no signs of cognitive impairment as determined by 
the neuropsychological criteria for HAND established by the National Institute of 
Mental Health and National Institute of Neurological Diseases and Stroke 
(Antinori et al., 2007).  
Many of the previous imaging investigations did not carry out a full 
neuropsychological assessment using the updated criteria for HAND to exclude 
HIV+ participants with asymptomatic neurocognitive impairment (ANI), mild 
neurocognitive disorder (MND), or HIV-associated dementia (HAD) (Becker et 
al., 2012; Küper et al., 2011; Thompson et al., 2005). Other authors actively 
recruited subjects with major cognitive deficits or dementia as part of their study 
(Aylward et al., 1993; Patel et al., 2002; Pomara et al., 2001; Ragin et al., 2004; 
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Wu et al., 2006), focused on a specific subset of the HIV+ population including 
the elderly (Nir et al., 2014), patients over 40 (Kallianpur et al., 2012) or 50 years 
old (Becker et al., 2012), children with vertical transmission (Hoare et al., 2015), 
patients with HIV subtype C (Hoare et al., 2011), or patients infected with the 
virus within 100 days of scanning (Ragin et al., 2015). Of those using the 
updated nosology for HAND, patients with ANI were considered neurologically 
asymptomatic, despite demonstrating impairment of documented by performance 
of at least 1.0 standard deviation (SD) below the mean for appropriate normative 
data on two or more of the composite ability domain scores (Zhu et al., 2013). 
 
Temporal Lobe. 
In the CAHIV+ participants, free from all levels of HAND, we identified 
temporal lobe alterations in both the white matter and cortex. These same 
regions showed an inverse relationship between each one another in the 
combined HIV group such that frontotemporal FA increased as cortex within the 
STG thinned. The same was true of the HAND group where frontotemporal FA 
increased as the STS decreased. STG thickness also correlated with poorer 
performance on the Attention/ Working Memory (AWM) cognitive domain score 
for the combined HIV+ group. The HAND participants demonstrated a negative 
correlation between the same AWM domain and frontotemporal FA such that FA 
increases as test performance decreases.  
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As is well-established in previous literature, basal ganglia dysfunction is 
associated with HIV infection (Berger and Arendt, 2000); anatomical research 
has identified direct connections between the STG and the caudate nucleus and 
putamen in monkeys (Yeterian & Pandya, 1998). Other work suggests that the 
STG is necessary for spatial processing (Mayer et al., 2004), and feature-based 
serial exploratory search tasks (Ellison et al., 2004). Given that HIV+ patients 
have been documented as having deficits in related spatial and attentional tasks 
(Grassi et al., 1999; Hinkin et al., 2002; Marcotte et al., 2004), it is unsurprising 
that we identified irregular measures in both the WM and cortex of the superior 
temporal lobe. 
 
Parietal Lobe. 
There was a significant decrease in parietal lobe FA for the CAHIV+ group 
compared to HIV- in Experiment #1. This parietal FA decrease correlated with 
increased plasma viral loads for the CAHIV+ group in Experiment #3. These 
results were unsurprising given that previous studies have reported reduced FA 
values in HIV+ participants (Chang et al., 2008; X. J. Li et al., 2015). When 
comparing the CAHIV+ and HAND groups in Experiment #2, mean thickness of 
the intraparietal sulcus was significantly decreased for HAND participants. 
Furthermore, Experiment #3 revealed that reduced cortical thickness measures 
of the intraparietal sulcus correlated with poorer performance on both the 
Memory (Learning and Recall) domain and overall global functioning score for 
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the combined HIV+ group. Global deficit scores have correlated with parietal lobe 
FA values in a previous report (Chang et al., 2008). Associations between 
increased angular gyrus thickness and both frontotemporal and posterior 
callosum elevated FA measures were also identified. Given that HIV-related 
impairment has been reported during parietal-dependent mental rotation tasks 
(Olesen et al., 2007; Weber et al., 2010) and fMRI investigations demonstrating 
posterior parietal hyperactivity (Castelo et al., 2006; Schweinsburg et al., 2012), 
the parietal lobe is clearly impacted by HIV illness. 
 
Occipital Lobe. 
While we did not identify WM alterations in the occipital lobe, a 17% 
increase in thickness was calculated in the inferior occipital gyrus (IOG) for the 
CAHIV+ participants as compared to the control group – a highly significant 
result. A recent PET study showed significant regional increases of 18 kDa 
translocator protein (TSPO) in the occipital lobe for HIV+ patients (Vera et al., 
2016). TSPO is a marker of inflammation and has been associated with poorer 
cognitive performance and white matter microstructural pathology. Immune 
activation leading to tissue swelling has been hypothesized in other reports of 
volume increases in the HIV+ population (Jernigan et al., 2011). Another possible 
explanation is that underlying white matter damage could result in increased 
thickness of the cerebral cortex in HIV. Whatever the direct cause, occipital lobe 
alteration may account for some of the visuospatial (Bogdanova et al., 2008; 
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Hinkin et al., 2002; Marcotte et al., 2004; Olesen et al., 2007) and attentional 
(Chang et al., 2004) difficulties previously documented in the HIV population. 
 
Corpus callosum. 
 White matter alterations in the corpus callosum have been well 
documented in HIV+ individuals (Hoare et al., 2011, 2012; Leite et al., 2013; X. J. 
Li et al., 2015; Müller-Oehring et al., 2010; Nir et al., 2014) and specifically 
identified in the genu (Corrêa et al., 2015; Filippi et al., 2001; Schulte et al., 2008; 
V. M. Tang et al., 2015; Thurnher et al., 2005) and splenium (Filippi et al., 2001; 
Wu et al., 2006).  Recently, reduced FA in the corpus callsoum has been found 
as early as within the first one hundred days of infection (Ragin et al., 2015). 
Experiment #1 highlighted increased FA in the posterior corpus callosum for the 
CAHIV+ individuals as compared to the HIV- group. No cognitive associations 
were identified for the posterior corpus callosum within the CAHIV+ group. 
However, in the combined HIV positive group (HIV+ and HAND), the left posterior 
callosum FA was inversely associated with both the Attention/Working Memory 
Domain and Verbal Fluency Domains, supporting the interpretation that 
increased FA in this sample is indicative of disease progression (as discussed 
above regarding the temporal and occipital lobes). Also consistent with this 
interpretation, increased viral load correlated with increased FA in the left 
posterior callosum for the combined HIV+ group.  
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OVERALL CONCLUSIONS 
Collectively, our results conclude that temporal, occipital, and parietal lobe 
dysfunction occurs in cognitively asymptomatic HIV+ individuals. The work in this 
thesis demonstrates that both white matter integrity and the cortical ribbon are 
regionally altered in the absence of HAND. Within a combined group of 
individuals spanning HAND classification, these same regions correlate with 
cognitive performance in neuropsychological domains known to be sensitive to 
HIV-related illness. Together, the results from these three studies suggest that 
regional FA and cortical alterations identified in the absence of HAND may 
contribute to the cognitive deficits seen in later stages of HIV disease. 
These findings significantly contribute to our understanding of the 
cognitively asymptomatic HIV-infected brain. While the lives of HIV+ individuals 
have been extended by highly active antiretroviral therapies, the prevalence of 
HAND continues to rise. HIV infection is becoming a chronic illness with few 
treatment options specifically designed to address the cognitive aspects. 
Understanding the path of HIV-infection in the central nervous system, when 
patients are free from cognitive illness, is crucial for the development of new 
treatments.  
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